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Abstract 
Dopamine (DA) transmission plays a critical role in the processing of emotionally 
salient information and in associative learning and memory processes. Within the 
mammalian brain, neurons within the medial prefrontal cortex (mPFC) are involved 
critically in the encoding, expression, and extinction of emotionally salient learned 
information. Within the mPFC, DAergic transmission is involved importantly in 
controlling attention related and motivational processes, particularly within the 
context of emotionally salient sensory information. Considerable evidence suggests 
differential roles for DA D1-like versus D2-like receptors, including the D4-receptor 
subtype, in the regulation of neuronal activity and emotional processing within the 
mPFC. Using behavioural models of emotional learning and memory in rats, 
including olfactory fear-conditioning and conditioned place preference assays, we 
compared the roles of DA D1-receptor versus D4-receptor activation during the 
encoding and recall phases of emotional learning and memory. We report that specific 
activation of DA D4-receptors within the mPFC strongly potentiates the salience of 
normally nonsalient emotional associative fear memories and blocks the encoding of 
suprathreshold conditioned fear associations and has no effect on memory recall. In 
addition, the bidirectional effect demonstrated by D4-receptor activation in the mPFC 
depends upon downstream signaling via CaMKII, cyclic-AMP/PKA, and PP1 
substrates. In contrast, intra-mPFC D1-receptor activation failed to increase the 
emotional salience of subthreshold fear stimuli but completely blocked the expression 
of previously learned aversive and rewarding memories. Interestingly, both intra-PLC 
  iii 
D1-receptor mediated block of either fear-related or reward-related associative 
memories were dependent upon downstream cAMP signaling as both effects were 
rescued by co-administration of a cAMP inhibitor. Taken together these results 
demonstrate that DA D4 versus D1 subtype receptor transmission within the mPFC 
plays distinct functional roles in the processing of emotionally salient versus 
nonsalient associative information and differentially modulates the encoding versus 
recall phases of emotional memory within the mPFC through distinct molecular 
signaling pathways. A clearer understanding of the specific roles of DA D1 and D4 
receptor transmission during emotional learning and memory may help elucidate how 
abnormalities in the mPFC neural circuitry may lead to aberrant associative learning 
and memory processes in disorders such as schizophrenia, drug addiction, PTSD and 
ADHD. 
Keywords: 
medial prefrontal cortex, dopamine, D4-receptor, D1-receptor, basolateral amygdala, 
ventral tegmental area, emotional learning, associative memory, fear conditioning, 
reward learning, post-traumatic stress disorder, schizophrenia, attention deficit 
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Chapter 1: General Introduction 
 
 
1 Dopamine receptor modulation of cortical neuronal 
network activity and emotional processing: Implications 










                                                 
1
 This chapter has been adapted from a published journal article:  Lauzon NM, Laviolette SR. (2010) 
Dopamine D4-receptor modulation of cortical neuronal network activity and emotional processing: 




The neural processing, encoding, and filtering of incoming sensory information are 
disturbed in a number of neuropsychiatric disorders. Common features underlying 
these deficits are the distortion of the emotional meaning and salience of sensory 
information, and perhaps more importantly, the ability to form adaptive associative 
memories between environmental stimuli and their appropriate motivational and 
emotional context. Thus, not only must sensory information be appropriately 
categorized and attended to according to emotional relevance and salience, we must 
be able also to accurately remember what these sensory cues mean, and associate 
them with appropriate behavioural and/or psychological responses, based on their 
emotional context. When these processes go awry, inappropriate assignment of 
emotional salience to normally unimportant sensory inputs may lead to misguided 
attention to these inputs; impulsive reactions to sensory cues; and in the extreme, 
psychotic ideation, delusional thinking and the persistence of maladaptive associative 
memories. 
 Given the complexity of these psychological processes, it is not surprising that 
a plethora of neurochemical systems and neuroanatomical substrates have been 
implicated as being critical for emotional processing and memory formation. A 
considerable body of evidence points to functional interactions between cortical and 
subcortical structures underlying the neuroplastic processes responsible for emotional 
processing, learning, and memory. Specifically, the neurotransmitter dopamine (DA) 
is well recognized as an essential modulator of these events. In the following chapter, 
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we will discuss evidence from both human and animal-based research demonstrating 
a role for functional interactions between the medial prefrontal cortex (mPFC) and 
associated subcortical inputs, the amygdala, and ventral tegmental area (VTA). We 
will examine how modulation of this neural circuitry, specifically through different 
DA receptor subtype populations, may be a critical regulator of emotional salience, 
associative memory encoding and neuronal plasticity events associated with normal 
and aberrant emotional processing and memory encoding.    
 The mPFC is well recognized as an important integrative centre for executive 
cognitive functioning and is crucial in the processing and filtering of emotionally 
relevant sensory information. Disturbances in the mPFC are evident in various 
neuropsychiatric conditions such as schizophrenia, addiction, ADHD, and post-
traumatic stress disorder (PTSD) (Goldman-Rakic, 1994; Shin et al., 2006). In terms 
of emotional integration, the mPFC receives critical inputs from both the VTA and 
amygdala, and DA receptor transmission within the PFC can modulate the inputs 
from both of these regions (Rubinstein et al., 1997; Ceci et al., 1999; Yuen et al., 
2009). The amygdala has been widely investigated for its role in normal emotional 
processing and has been implicated in a variety of psychiatric conditions. 
Specifically, the basolateral region of the amygdala (BLA) has been generally viewed 
as a sensory integration site, receiving inputs from the visual, auditory, somatosensory 
(including pain), and olfactory systems (LeDoux, 2007). Human studies have 
implicated the BLA-mPFC pathway in fear conditioning and extinction of fear 
memories (Phelps et al., 2004). Previous reports have demonstrated that functional 
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interactions between the BLA and mPFC in rodents are critical for encoding learned 
emotional associations at the level of the single neuron, and in behaving animals 
(Laviolette et al., 2005; Laviolette & Grace, 2006a; Rosenkranz & Grace, 2002; 
Rosenkranz et al., 2003). In terms of emotional processing and perception, structural 
and functional abnormalities in the BLA and mPFC regions have been reported in 
schizophrenic subjects (Lawrie et al., 2003; Crespo-Facarro et al., 2000; Taylor et al., 
2002; Williams et al., 2004; Gur et al., 2002). Specifically, human imaging studies 
have found significant contribution of these areas to altered brain activity in patients 
with psychiatric conditions such as schizophrenia and PTSD (Herbener et al., 2007; 
Whitfield-Gabrieli et al., 2009; Gilboa et al., 2004; Shin et al., 2004).  
 Electrophysiological investigations have demonstrated a subpopulation of 
neurons within the mPFC is capable of encoding and expressing emotional 
conditioned associations via inputs from the BLA (Laviolette, 2005; Laviolette & 
Grace, 2006a, b). Using in vivo, intracellular recordings, Rosenkranz & Grace (2002) 
demonstrated that single neurons within the rodent BLA could encode emotional 
associative learning through a DA-dependent mechanism. At the neurochemical level, 
abnormalities in DAergic signaling within the mesocorticolimbic system have been 
implicated in the underlying pathology of aberrant emotional processing observed in 
numerous psychiatric conditions (Moore et al., 1999; Hall et al., 2004). Consequently, 
increasing evidence from clinical, genetic, behavioural, and electrophysiological 
investigations demonstrates critical and distinct roles for DA D1-like versus D2-like 
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receptors, including the D4 receptor subtype, in the regulation of neuronal activity and 
emotional processing within the mPFC neural circuitry. 
1.2 Dopamine Modulation of mPFC Neuronal Networks 
Various anatomical mapping studies using human, rodent and primate models have 
localized the D1, D4 receptor subtypes to cortical, and subcortical neural regions 
involved in emotional processing, learning, and memory. In particular, several studies 
have reported relatively higher concentrations of the D4-receptor subtype within the 
PFC, amygdala, hippocampus, thalamus, caudate putamen, and cerebellum, with 
relatively less distribution within the mid-brain and striatal regions (O’Malley et al., 
1992; Meador et al., 1994; Primus et al., 1997; Ariano et al., 1997; Khan et al., 1998; 
Defagot et al., 1997) while the D1 receptor has been localized within PFC, caudate, 
putamen, substantia nigra, nucleus accumbens and olfactory bulb (Goldman-Rakic et 
al., 1992; Farde et al., 1987; Beaulieu et al., 2011). Therefore, both human and rodent 
localization of D1 and D4 receptors strongly suggest a distribution within neural 
regions important in executive function and emotional regulation (Ariano et al., 1997; 
Khan et al., 1998; Defagot et al., 1997; O’Malley et al., 1992; Meador et al., 1994; 
Primus et al., 1997). The following chapter will review clinical, genetic, behavioural, 
and electrophysiological evidence for the specific roles of the DA D1 and D4 receptor 
subtypes in mPFC and the implications for cognitive and emotional processes.  
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1.2.1 Evidence linking the D1-receptor to learning and memory 
DAergic modulation of mPFC neuronal networks is known to control the encoding of 
working memory and the temporal sequencing of behavioural output (Goldman-
Rakic, 1995; Goldman-Rakic et al., 1989; Seamans et al., 1998). Previous 
investigations have demonstrated that intra-mPFC activation of D1 receptors impairs 
spatial working memory performance (Zahrt et al., 1997) and delayed response 
performance (Arnsten et al., 1994; Cai & Arnsten, 1997). In addition, Takahashi et al 
(2008 & 2012) have demonstrated that individual differences in D1 receptor 
availability in the brain predicted differences in working memory, emotional reaction 
and decision making better than that of D2 receptor availability. Current theories of 
mPFC DAergic function have suggested that D1 receptor transmission may be critical 
for the preservation and expression of memories over temporal delay periods 
(Durstewitz & Seamans, 2008), although few studies have examined directly the role 
of mPFC D1 receptor transmission during the expression of emotionally salient 
associative memories. Seamans et al. (1998) reported that blockade of mPFC D1 
receptors blocked the ability of rodents to use previously acquired spatial memory 
during a delayed performance radial arm task, while having no effect on non-delayed 
memory expression. These studies suggest that executive memory functions within 
mPFC neuronal networks may require an optimal level of DA D1 signaling, 
specifically during periods of memory expression, rather than during associative 
memory encoding. Several rodent and primate studies have shown that too much or 
too little D1 receptor stimulation impairs mPFC function, demonstrating an inverted 
U-shaped dose response curve (Arnsten et al., 1994; Sawaguchi and Goldman-Rakic, 
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1994; Williams and Goldman-Rakic, 1995; Zahrt et al., 1997; Goldman-Rakic, 2000; 
Williams & Castner, 2006; Cools & D’Esposito, 2011). Thus, while low level D1 
receptor stimulation tended to enhance neuronal spatial tuning during a spatial 
working memory task, high stimulation levels impaired performance both at the 
neuronal and behavioural levels. Similarly, Vijayraghavan et al. (2007) demonstrated 
that excessive D1 receptor stimulation induces nonselective decrease of mPFC neural 
activity in a spatial working memory task. This is consistent with the finding that a D1 
receptor agonist increased interneuron excitability and the frequency of inhibitory 
postsynaptic current in amygdala projection neurons, as will be discussed in detail to 
follow (Kröner et al., 2005). Taken together, these investigations provide evidence of 
a crucial role of the DA D1 receptor in adaptive learning and memory processes. Next, 
we will outline a potential role for DA D1 receptor signaling in memory related 
neuropsychiatric disorders such as drug addiction, PTSD, and schizophrenia. 
1.2.2 D1 receptor: potential implications for memory-related 
neuropsychiatric disorders 
Perturbations in DA transmission are well-established correlates related to both the 
rewarding and dependence producing properties of most drugs of abuse (Wise, 2004). 
D1 receptor signaling may be critical for the expression of drug related memories. 
Previous research has suggested that the retrieval of morphine-related associative 
memories is more likely to occur in the presence of the morphine-conditioning cue 
during expression testing (Izquierdo & Dias, 1983; Darbandi et al., 2008). In addition, 
a human imaging study suggests that reduced D1 receptor binding in the mPFC is 
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associated with an increased risk of relapse in cocaine addiction (Martinez et al., 
2009). In the context of addiction-related memories, neurons within the mPFC both 
encode and express associative memories linked to the rewarding properties of 
opiates (Sun et al., 2011; Sun and Laviolette, 2012). Furthermore, activation of mPFC 
neuronal circuits is linked to various drug-seeking behaviours (Daglish et al., 2001; 
Luo et al., 2004; Koya et al., 2006; Langleben et al., 2008). The formation and 
persistence of these drug-related associative memories can trigger drug-seeking 
behaviours or relapse in response to drug-associated stimuli (de Wit and Stewart, 
1981; Ehrman et al., 1992). Indeed, considerable evidence has linked D1 receptor 
transmission to psychostimulant drug-related memory expression. For example, D1 
receptor activation has been shown to decrease cocaine-seeking behaviour in rats, 
whereas D2 receptor activation triggers cocaine-seeking behaviour and relapse (Self et 
al., 1996). In addition, D1 receptor activation has been reported to induce extinction-
like behaviours in rats that have previously acquired cocaine-related self-
administration behaviours, suggesting that stimulation of D1 transmission may 
degrade previously acquired drug-related associative memories (Self et al., 2000).  
 The obtrusive and spontaneous expression of associative memories linked to 
either traumatic or highly rewarding experiences may be a critical factor underlying 
the pathological features of disorders such as PTSD or addiction. PTSD patients may 
associate a wide variety of sensory stimuli with intense fear (Rothbaum & Davis, 
2003). While the specific role of D1 signaling in the context of PTSD has not been 
extensively examined in clinical populations, abnormally low levels of cyclic 
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adenosine monophosphate (cAMP) signaling have been found to be a persistent 
correlate of PTSD in clinical populations (Kolb, 1989) leading to the suggestion that 
lowered cAMP signal transduction may serve as a clinical biomarker for PTSD (Lerer 
et al., 1987). DA D1 receptor stimulation is critically linked to downstream regulation 
of cAMP (Senogles et al., 1988). Together with the well-established profound 
decreases in cAMP levels observed in PTSD clinical populations, the present results 
may have implications for understanding how DA D1-mediated inhibition of cAMP 
levels may modulate spontaneous expression of traumatic associative memories 
through mPFC-dependent memory circuits. Indeed, considerable evidence points to 
neuropathological abnormalities within frontal cortical regions of PTSD patients as 
potential clinical correlates of PTSD-related memory disturbances and lack of control 
over traumatic memory expression (Tavanti et al., 2012 and Carrion et al., 2009). 
 Considerably less research has been completed on the implications of D1 
receptors in schizophrenia than D2 receptors; however, evidence may suggest a role 
for D1 receptors in the cognitive deficits experienced by schizophrenic patients. Abi-
Dargham et al. (2002) discovered that an increase in D1 receptors in the PFC was 
associated with working memory impairment in schizophrenia. An additional human 
imaging study by the same researcher found an increase in D1 receptor binding in 
drug naïve schizophrenic patients, but not in patients who had previously been treated 
with antipsychotics (Abi-Dargham et al., 2012). This study suggests that the increase 
is due to schizophrenia itself and may be normalized during drug treatment of the 
illness. In addition, Golman-Rakic et al. (2004) found working memory deficits could 
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be ameliorated by treatments that increase D1 receptor stimulation, indicating that this 
target presents a unique opportunity for the restoration of cognitive function in 
schizophrenia. Taken together, the above provide evidence for the crucial role of DA 
D1 receptors in prefrontal cortex function, including working memory. In addition, D1 
receptor aberrant transmission implicating D1 receptor transmission as a possible 
correlate of the memory related cognitive deficits seen in drug addiction, PTSD, and 
schizophrenia. These findings further implicate the PFC as a critical neural substrate, 
wherein transmission via the D1 receptor may play a crucial during the expression of 
emotionally salient associative memories.  
1.2.3 D4 receptor: potential implications for schizophrenia 
Since the advent of the atypical antipsychotic clozapine, and subsequent discovery of 
the D4 receptor, a wide variety of clinical genetic linkage studies have examined 
possible correlations with D4 receptor expression and neuropsychiatric disorders 
including schizophrenia, attention-deficit disorder (ADHD), addiction and depression. 
Although most research attention surrounding the DA theory of schizophrenia has 
concentrated on the D2 receptor, there is increasing evidence to support an important 
role specifically for the DA D4 receptor subtype in various neuropsychiatric disorders. 
Human postmortem analyses have conflicting results, with some reporting a 
significant increase in D4 receptor binding in the putamen, nucleus accumbens, 
caudate nucleus and entorhinal cortex of patients with schizophrenia, relative to 
controls (Seeman et al., 1993; Murray et al., 1995; Sumiyoshi et al., 1995; Lahti et al., 
1998). While others have failed to show a difference in D4 binding levels in the 
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frontal cortex or striatal regions of patients with schizophrenia versus control subjects 
(Mulcrone & Kerwin, 1996; Reynolds & Mason, 1995).  
 The DA D4 receptor displays highly polymorphic variations in the coding 
sequence in the human population (Van Tol et al., 1992). One polymorphism linked 
to schizophrenia is located in the third exon of the gene, which forms the third 
intracellular loop and may contribute to the binding characteristics of the receptor. 
The 48-base-pair element encoding a 16 amino acid chain within the third exon has a 
variable number of tandem repeats (VNTR) ranging from 2 to 11 in humans (Litcher 
et al., 1993; Ding et al., 2002). There is a significantly higher frequency of the long 
form of the D4 allele in patients with schizophrenia relative to normal controls (Weiss 
et al., 1996; Lung et al., 2006). Aguirre et al. (2007) performed an association 
analysis of exon III and I polymorphisms of the D4 receptor locus and found an 
excess of “rare” alleles (3–, 5–, 6– and 8–48 repeats) in a sample of psychotic 
Mexican patients. In addition, Nakajima et al. (2007) reported that upstream gene 
promoter variants appeared to confer susceptibility to schizophrenia in Japanese 
psychiatric patients. In contrast, several reports have suggested a lack of genetic 
linkage between the D4 receptor and schizophrenia (Mitsuyasu et al., 2007; Lee et al., 
2007; Ambrosio et al., 2004). Clearly, genetic linkage studies examining the potential 
etiological role of the D4 receptor in clinical populations with schizophrenia are 
controversial at best. However, some recent evidence using physiogenomic analysis 
of D4-related genes combined with functional magnetic resonance imaging (fMRI) 
have yielded some intriguing results. For example, Windemuth et al. (2008) reported 
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that abnormalities in fMRI responses during an auditory ‘oddball’ task in patients 
with schizophrenia were related to single nucleotide polymorphisms including the DA 
beta-hydroxylase gene and the D4 receptor gene. Given the rather overwhelming 
variability of these studies, clearly further studies are required to accurately 
characterize the potential functional role of D4 receptor gene expression in the 
symptomology and/or etiological course of schizophrenia.  
1.2.4 The role of the D4 receptor in impulsivity and novelty 
seeking: implications for ADHD 
Increasing evidence from both human and animal-based research links disturbances in 
D4 receptor transmission to psychiatric disorders associated with impulsivity, most 
notably, attention-deficit hyperactivity disorder (ADHD). Although ADHD is a 
complex syndrome, cardinal features of the disorder are characterized by 
inappropriate attention or lack thereof, hyperactivity, and impulsivity (APA DSM IV, 
2000). Brain imaging studies have shown that subjects with ADHD have a 
characteristically smaller brain volume (Rapoport et al., 2001) specifically, within the 
bilateral mPFC and anterior temporal cortices (Sowell et al., 2003), both regions 
implicated in the processing of emotionally salient information (Laviolette et al., 
2007; Laviolette & Grace, 2006a). It has also been shown that in adults with ADHD 
there is a decrease in DOPA decarboxylase activity in the mPFC, which is responsible 
for converting the precursor of DA into functional DA (Ernst et al., 1998). Increased 
levels of DA transporter expression have been reported in patients with ADHD 
(Dougherty et al., 1999), further implicating a role for disturbed DA transmission as 
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an underlying factor in this disorder. In line with this, considerable evidence now 
links dysregulated expression and signaling of the DA D4 receptor in the 
pathophysiology of ADHD (Leung et al., 2005). 
 Psychological measures of novelty seeking have been conceptually linked to 
impulsive behavioural traits and several studies have linked the D4 receptor to 
measures of novelty seeking. One polymorphism in particular that has been 
investigated for possible association with novelty seeking traits is the 5′ region 
−521C/T polymorphism, which reduces D4 receptor transcriptional efficiency 
(Okuyama et al., 2000). The C-521T polymorphism has also been associated with 
approach-related behaviours such as extroversion, sensation seeking, impulsivity, and 
novelty seeking (Okuyama et al., 2000; Mitsuyasu et al., 2001; Ronai et al., 2004; 
Golimbet et al., 2007). In two high impact back-to-back publications, the long allele 
of the D4 exon III polymorphism was correlated with a significant increase in the 
frequency of novelty seeking as a personality trait (Benjamin et al., 1996; Ebstein et 
al., 1996). Although some subsequent studies have also found an association between 
personality traits and the length of the VNTR (Nobel et al., 1998; Strobel et al., 1999; 
Tomitaka et al., 1999; Lee et al., 2003; Lynn et al.,2005; Kim et al., 2006; Serretti et 
al., 2001), others have failed to find such associations (Jonsson et al., 1997; Hill et al., 
1999; Persson et al., 2000; Schinka et al., 2003; Munafo et al., 2008). Thus, similar to 
genetic linkage studies examining correlations between D4-receptor expression and 
schizophrenia, there is considerable controversy concerning the potential role of the 
D4-receptor gene in the etiology of ADHD. 
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 Various animal models have similarly reported functional roles for the D4 
receptor in novelty/impulsive behavioural phenomena. Duwala et al. (1999) reported 
that mice with genetic deletion of the D4 receptor demonstrated decreased exploration 
and approach towards novel stimuli. However, a subsequent report using this genetic 
knockout model reported no effects of D4-receptor deletion on other impulsivity 
assays such as ‘Go/No-Go’ and measures of response inhibition (Helms et  al., 2008). 
Nevertheless, Bailey et al. (2007) used a non-human primate model (the vervet 
monkey) to correlate polymorphisms in the D4-receptor gene with novel object 
approach assays and found that variants in D4 receptor expression could account for a 
significant portion of the total variance in novelty seeking measures. Thus, although 
controversial, evidence at the genetic and behavioural levels of analysis suggests a 
link between variations in D4 receptor expression, novelty/impulsivity and the 
presence of behavioural/psychological traits associated with ADHD.  
1.2.5 Evidence linking the D4 receptor to addictive behaviours 
Despite the complexity of addiction in terms of underlying psychological variables 
and neuropathological correlates, it is reasonable to suggest that, similar to other 
neuropsychiatric disorders such as schizophrenia and ADHD, an important feature 
common to addictive behaviours are disturbances in emotional processing, learning, 
memory and impulsive behaviours. Similar to human and animal investigations 
examining schizophrenia and ADHD-related phenomena, increasing evidence points 
to a role for the D4 receptor as an underlying factor related to addiction. Using a 
genetic knockout mouse model, Rubinstein et al. (2001) reported that genetic deletion 
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of the D4 receptor led to a behavioural phenotype comprising locomotor 
supersensitivity to several drugs of abuse, including ethanol, cocaine, and 
methamphetamine. Genetic deletion of the D4 receptor gene was also reported to 
potentiate the discriminative effects of cocaine (Ktaz et al., 2003), as well as a 
decreased reward sensitivity to methamphetamine and amphetamine (Thanos et al., 
2009). In addition to these animal models of reward and addiction, a number of 
clinical studies using human patient populations have suggested a link between D4 
polymorphisms and the occurrence of opiate and/or alcohol abuse. For example, two 
early studies revealed alleles of the D4 receptor exon III VNTR, as being positively 
correlated with heroin abuse in both Chinese psychiatric patients (Li et al., 1997) and 
in heroin addicted subjects in Israel (Kotler et al., 1997). However, a later report from 
Franke et al. (2000) failed to observe any differences in this D4 receptor 
polymorphism in samples of heroin-dependent addicts relative to controls in German 
population samples. A more recent study reported that significantly greater cue-
induced craving for heroin was observed in heroin-dependent Chinese subjects 
carrying the D4 VNTR long-type allele, relative to non-dependent controls (Shao et 
al., 2006). This finding is particularly interesting given the well established role for 
DA transmission in drug-related memory recall (Wise, 2004; Goldstein & Volkow, 
2002) and evidence demonstrating that D4-receptor transmission within the PFC is 




 D4 receptor polymorphisms have also been associated with alcoholism. 
Genetic linkage studies performed by Hill et al. (1999) found evidence of modest 
linkage between polymorphisms near the D2 and D4 receptor genes between measures 
of physical dependence and early onset of alcoholism in families with histories of 
chronic alcoholism. In addition, Hutchison et al. (2002) revealed that subjects with 
polymorphisms in the D4 receptor long variant, displayed higher levels of alcohol 
craving following consumption of alcoholic beverages. In terms of interactions 
between psychometric measures of novelty seeking and co-morbidity with 
alcoholism, Sander et al. (1997) reported no significant correlation between 
expression of the D4 receptor exon III and measures of novelty seeking amongst 
alcoholic subjects. However, a subsequent study by the same group found a 
significantly higher prevalence of the 7-repeat allele alcoholic individuals compared 
to the control sample (Franke et al., 2000). Furthermore, a study by Ray et al. (2009) 
reported a significant direct path between the D4 receptor VNTR genotype and 
alcohol abuse, with novelty seeking traits as the qualifying mediator between 
variables. Thus, similar to previously described linkage studies between D4 receptor 
polymorphisms and the occurrence of schizophrenia and ADHD, further studies are 
required to elucidate the potential role of D4 receptor expression abnormalities in 
addiction related phenomena. Given the predominant localization of the D4 receptor 
within PFC circuits that are essential to executive control and response inhibition, 
these studies collectively, suggest an important role for D4 receptor transmission 
within this cortical circuitry for the processing and filtering of emotionally salient 
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sensory information and in the control of appropriate behavioural responding to such 
inputs. 
1.2.6 Dopamine D4 receptor transmission modulates emotional 
memory encoding and learning in cortical and subcortical 
circuits 
Early behavioural studies using D4 receptor knockout mice demonstrated 
motivational/emotional abnormalities such as decreased expression of behavioural 
inhibition when tested in open field tests or the elevated plus maze, and enhanced 
reactivity in response to unconditioned (but not conditioned) fear stimuli (Avale et al., 
2004; Falzone et al., 2002). In addition to rodent behavioural studies employing 
genetic knockout techniques, several studies have used more traditional behavioural 
pharmacological approaches to examine the role of D4 receptor signaling within the 
PFC during neuronal encoding of emotional associative learning and memory. Using 
a cognitive set-shifting task, Floresco et al. (2006) reported that intra-PFC 
microinfusions of a D4 receptor agonist impaired, whereas microinfusions of a D4 
receptor antagonist improved behavioural measures of set shifting in rats. Their 
findings suggested that executive cognitive flexibility requires an optimal level of D4 
receptor activation within the PFC. Laviolette et al. (2005), using single-unit 
extracellular recordings, isolated single neurons within the rat PFC that responded to 
electrical stimulation of the BLA. Rats were then given an olfactory fear conditioning 
procedure wherein specific olfactory cues (CS) were paired with footshock (US). 
Systemic pre-treatment with a competitive antagonist of the D4 receptor, L-741,741 
completely blocked the ability of PFC neurons to associatively encode olfactory cues 
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paired with footshock, suggesting that D4 receptor transmission within the PFC is 
essential for the encoding of emotionally salient memories. Furthermore, direct 
microinfusions of the same D4 antagonist into the PFC prevented also the encoding 
and behavioural expression of associative olfactory fear learning, while having no 
effect on the behavioural or neuronal sensitivity to footshock presentation, in and of 
itself. One report using the atypical antipsychotic drug clozapine showed a dose-
dependent attenuation in the acquisition of behavioural response to fear conditioning 
at significantly lower doses than those required for typical antipsychotics (Inoue et al., 
1996). This inhibition of conditioned fear response was significantly correlated with 
Ki values for the DA D4 receptors, but not with other acetylcholine or monoamine 
receptors. This study demonstrated also that clozapine did not the affect the 
expression phase of fear conditioning. These results further suggest an important role 
specifically for the D4 receptor, in the mediation of clozapine's effects on emotional 
processing and memory encoding. Taken together with previously noted studies 
implicating abnormal expression patterns for the D4 receptor as a possible correlate of 
emotional processing disorders like schizophrenia, ADHD and depression, these 
findings further implicate the mPFC as a critical neural substrate wherein 
transmission via the D4 receptor may control not only the emotional amplitude of 
incoming sensory information, but may be crucial for the normal associative encoding 




 Thus far, we have presented electrophysiological, clinical, genetic, and 
behavioural evidence that that mPFC is a critical area involved in normal cognitive 
functioning, and that disruptions involving DA receptors modulation within the 
mPFC have been implicated in several psychological disorders. In addition, the 
regulation of pyramidal neuron activity by the DA receptors is considered a 
fundamental aspect of associative learning and memory processes (Goldman-Rakic 
1995; Seamans et al., 2004; Sobotka et al. 2005; Nowak et al. 2012). We will now 
examine evidence demonstrating different roles for the DA D1 and D4 receptors in the 
regulations of neuronal activity within the mPFC circuitry. 
1.3 D1 and D4 receptor transmission within mPFC  
Projections from the BLA and DA input from the VTA in the mPFC, forming a neural 
circuit important in executive function and emotional regulation. However, the role 
that DA plays in modulating neurotransmission and connectivity in the BLA-mPFC 
pathway is relatively unknown. Consistently, both human and rodent receptor 
mapping studies report high expression levels of the D1 and D4 receptors in the mPFC, 
strongly suggesting a localized distribution to modulate neuronal activity within this 
neural circuitry (Ariano et al., 1997; Khan et al., 1998; Defagot et al., 1997; O’Malley 
et al., 1992; Meador et al., 1994; Primus et al., 1997). The mPFC comprises a 
heterogeneous population consisting of various neuronal types, including intrinsic 
interneurons and pyramidal output neurons. Interestingly, several post-mortem 
schizophrenic pathology studies have found significantly decreased numbers of 
GABA-containing interneurons within mPFC regions (Tooney & Chahl, 2004; 
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Chance et al., 2005; Mirnics et al., 2000). Because these inhibitory interneurons 
normally provide tonic inhibitory regulation of the pyramidal output neurons within 
the cortex, such disturbances are believed to represent abnormal neuronal regulation 
within the cortex and may be related to the emotional processing and cognitive 
disturbances observed in schizophrenia (Whitford et al., 2005). A considerable 
amount of research using electrophysiological recordings in vitro and in vivo, 
demonstrates different roles for DA D1 and D4 receptor subtypes in modulating 
neuronal network dynamics within the PFC. For example, using in vivo extracellular 
recordings within the rat BLA-PFC pathway, Floresco and Tse (2007) reported that 
the ability of BLA stimulation to inhibit pyramidal neuron activity in the PFC was 
dependent upon both D1 and D2/D4 receptor activities as pharmacological over-
activation of both receptor subtypes, and led to an attenuation of BLA-evoked 
suppression of spontaneous neuronal activity within the PFC neurons receiving input 
from BLA neurons. This study reported an important dissociation between D1-
receptor and D2/D4 receptor-mediated modulation of BLA inputs to the PFC: D1-
receptor activation blocked the excitatory effects of BLA stimulation on spontaneous 
PFC neuronal activity while D2 or D4 receptor activation blocked the ability of BLA 
stimulation to inhibit spontaneous activity within the PFC. This dynamic activity is 
consistent with the proposed functional arrangement of D4 versus D1-receptor 
localization on pyramidal versus interneuron neuronal populations within the PFC 
with D1 receptor activation increasing the intrinsic excitability of inhibitory gamma-
aminobutyric acid (GABA)ergic interneurons and D2-like receptor activation 
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decreasing the activity of these interneurons, presumably leading to decreased 
probability of tonic inhibitory GABA release within the mPFC (Seamans et al., 2001).  
 Indeed, at the cellular level, mPFC D4-receptor mapping reveals the presence 
of D4 receptors on both pyramidal and non-pyramidal interneurons, within the mPFC. 
Interestingly, Mrzljak et al. (1996) reported a preferential distribution of D4 receptors 
on populations of intrinsic GABAergic interneurons within several brain regions, 
including the mPFC, hippocampus, and various thalamic nuclei. Similarly, D1 
receptors have been localized to both pyramidal neurons and interneuron populations 
within the mPFC, with a majority of studies demonstrating a greater proportion of the 
D1 receptors on GABA containing inhibitory interneurons, compared to pyramidal 
neuron populations (Vincent et al., 1993; Sesack and Bunney, 1989; Bergson et al., 
1995; Yang and Seamans, 1996; Muly III et al., 1998; Gorelova et al., 2002; Gao and 
Goldman-Rakic, 2003; Santana et a., 2009). Therefore, DA D1 and D4 receptors are 
functionally located to exert both direct and indirect modulation of local neuronal 
network activity, including inhibitory interneurons to alter excitability of pyramidal 
output neurons (Gao & Goldman-Rakic 2003). Therefore, our aim is to determine the 
mechanism underlying the DA D1 and D4 mediated differential control of mPFC 
pyramidal neuron activity in modulating emotional associative learning and memory 
processes. Functionally, DA transmission within the mPFC influences neuronal 
network activity in a biphasic manner, with D2-like receptor activation decreasing the 
activity of GABAergic interneurons, and D1 receptor activation increasing the 
intrinsic excitability of these inhibitory interneurons (Seamans et al., 2001). 
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Specifically, activation of D1 receptors increases the activity of adenylate cyclase, in 
turn increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and 
protein kinase A (PKA; Kebabian & Calne, 1979). Figure 1.1 presents a simplified 
schematic showing this functional arrangement, whereby activation of DA receptors 
on inhibitory interneuron populations within mPFC may in turn increase or decrease 
inhibition of pyramidal output neurons from the mPFC, via network interactions with 
both VTA and BLA inputs converging upon mPFC pyramidal and GABAergic 
interneuron populations (Fig. 1.1).   
1.3.1 D1 receptor specific modulation of neuronal activity in mPFC 
Within mPFC neuronal circuits, electrophysiological evidence demonstrates that D1 
activation increases both cAMP and PKA levels, resulting in phosphorylation of K+ 
channels to decrease conductance, and cause increased excitability of interneurons 
and increased GABA release onto the postsynaptic pyramidal cell leading to 
feedforward inhibition of mPFC pyramidal output neurons (Starr, 1987; Kebabian & 
Calne, 1979; Laviolette & Grace 2006b; Seamans et al., 2001). Similarly, Kroner et 
al., (2005) found that a D1 receptor agonist increased interneuron excitability and the 
frequency of inhibitory postsynaptic current in mPFC pyramidal neurons projecting to 
the BLA. In addition, Trantham-Davidson et al. (2004) found that D1 antagonists and 
protein kinase A (PKA) inhibitors blocked the enhancement of GABA inhibitory 
currents, and that this was dependent upon the activation of the D1-cAMP/PKA 








Figure 1.1 A simplified schematic illustration demonstrating some of the known 
functional connections between the VTA, BLA and PFC.  
The VTA provides DA input to the PFC via the mesocorticolimbic pathway. Given the 
importance of the VTA in emotional and motivational information processing, one 
possibility is that these DA inputs provide emotional and/or motivational salience 
information to target neurons within the PFC. Glutamatergic inputs from the BLA to the 
PFC are importantly involved in transmitting emotionally salient associative encoding 
information to target neurons within the PFC. For simplicity, we show only ascending 
PFC inputs from the VTA and BLA, respectively; however, it is important to note that 
PFC neuronal populations send functionally important descending projections to both the 
VTA and BLA which may in turn regulate recurrent inputs from these regions back up to 
the PFC. While D1 and D4 receptors are found on both interneurons and pyramidal 
neuron populations, considerable evidence suggests a functional localization on intrinsic, 
inhibitory interneurons within the PFC. Thus, activation of DA D4 receptors through 
VTA > PFC inputs can inhibit or disinhibit feed-forward inhibitory influences on 
pyramidal output neurons, which may amplify or attenuate the emotional salience or 
associative memory magnitude of inputs from either the VTA or BLA that form 













 Furthermore, Vijayraghavan et al., (2007) found that moderate D1 receptor 
stimulation has been shown to spatially ‘tune’ PFC neurons that  process target 
signals by preferentially suppressing non-target (noisy) neural activities, whereas 
excessive D1 receptor stimulation induces nonselective suppression of PFC neural 
activities, irrespective of whether the neural activities are task related or not. They 
also demonstrated that co-administration of a cAMP activator can rescue the 
cognitive impairment induced by intra-mPFC D1 receptor overstimulation in primates 
performing a delayed spatial memory task, further demonstrating the important 
functional link between intra-cortical D1 receptor transmission and cognitive 
processing (Vijayraghavan et al., 2007). Given that neuronal populations within the 
mPFC are active during associative memory recall processes linked to both aversive 
and rewarding events, increasing cAMP/PKA signaling within the mPFC via D1 
receptor activation may lead to increased feedforward inhibition on mPFC pyramidal 
neurons, thereby impairing the expression of olfactory fear associations or opiate 
reward associations (Starr, 1987; Seamans et al., 2001; Laviolette & Grace, 2006b). 
Furthermore, evidence suggests that D1 receptor stimulation had a suppressive effect 
on the PFC neural activities involved in a spatial working memory task. Taken 
together, we propose that D1 receptor activation exerts its effects on mPFC pyramidal 
output neurons through a modulation of intrinsic inhibitory GABA containing 





Figure 1.2 An alternative framework for PFC D1-receptor-mediated modulation of 
emotional processing and memory expression based on molecular evidence 
demonstrating a role for PFC D1 signaling in the control of GABAergic containing 
inhibitory interneurons. 
A simplified hypothetical model for the relationship of D1 receptor stimulation and 
expression of associative memories. D1 receptor activation preferentially enhances 
glutamatergic (GLUT) inputs to GABAergic interneurons leading to a reduction in 
pyramidal cell activity via a GABA mediated increase of inhibitory post-synaptic 
currents (IPSC). Increased GABA interneuron activity would result in a feed forward 
inhibtions and therefore a decrease in pyramidal neuron output activity.  
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 In this hypothetical model, we present a simplified schematic demonstrating 
how D1-receptor-mediated modulation of inhibitory GABA transmission in the PFC 
may control the expression of emotional information. We have excluded the potential 
roles of D1-receptor-mediated modulation of NMDA receptors and/or AMPA-
receptor substrates associated with PFC interneurons. Although these mechanisms 
may be important, there is insufficient previous research to demonstrate a specific 
role during emotional learning and memory. Therefore, we propose that during the 
recall of emotionally salient memories PFC neuronal activity in emotional memory 
encoding networks would be susceptible to disruptions in D1-receptor signaling (as 
may be present in disorders such as addiction or PTSD), which in turn could increase 
cAMP and PKA substrates within GABAergic interneurons, leading to an increase in 
activity. This could theoretically lead to an increased magnitude of inhibitory 
modulation of pyramidal output neurons and thus, a resultant block of emotionally 
associative memory recall. Interestingly, in the context of reward-related learning and 
memory, previous evidence has demonstrated that cAMP/PKA stimulation or 
inhibition directly within the nucleus accumbens can disrupt the acquisition of 
reward-related memory, specifically, the acquisition of amphetamine-conditioned 
CPP (Beninger et al., 2003). Thus, cAMP/PKA signaling may be critical not only for 
the expression of drug reward-related memories, but may be necessary for the 
acquisition of these memories as well. 
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1.3.2 D4 receptor specific modulation of neuronal activity in mPFC  
In addition, considerable evidence using molecular approaches demonstrates an 
important role for the D4 receptor in the modulation and regulation of various 
downstream signaling molecules and/or functionally related receptor systems that are 
critical for plasticity related to learning and memory. For example, using an in vitro 
neuronal dissociation procedure, Wang et al. (2003) examined the effects of D4-
receptor transmission in isolated pyramidal neurons from PFC tissue in rats. They 
reported that application of a D4 receptor agonist could strongly decrease NMDA 
receptor currents and induced a reduction of the amplitude of evoked NMDA 
excitatory post-synaptic potentials in PFC slices. Furthermore, activation of D4 
receptors reduced the membrane surface expression of NMDA receptors and induced 
internalization of NMDA receptors through a CaMKII-dependent mechanism. Given 
the well established role of NMDA receptor plasticity in various forms of neuronal 
synaptic plasticity related to learning and memory, these results demonstrated for the 
first time an important molecular link between PFC D4 receptors and associated 
NMDA receptor complexes, providing a potential mechanism by which intra-PFC D4-
receptor transmission may modulate learning and memory processing (Yashiro et al., 
2008). In addition, the reported ability of D4 receptor activation to decrease NMDA 
receptor activity within the PFC are particularly interesting given the known 
psychotomimetic effects of NMDA receptor antagonist drugs, which have been 
proposed as a model of schizophrenia-related psychosis (Javitt et al., 1991;  Jenstsch 
et al., 1998).  
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 Indeed, the ability of D4-receptor activation to produce NMDA receptor 
hypofunction within the PFC, further suggests a potential mechanism by which 
abnormalities in D4-receptor transmission may be related to schizophrenia-like 
psychosis. In vitro evidence demonstrating a reduction in NMDA receptor expression 
in PFC pyramidal neurons following D4 receptor activation (Wang et al., 2003) may 
suggest that D4-receptor-mediated modulation of GLUT substrates within the PFC 
may act specifically via NMDA receptor substrates during the encoding of highly 
salient emotional associative information. However, D4 mediated reduction in NMDA 
receptor expression may not play a role in the modulation of emotional salience 
magnitude, since D4 receptor activation potentiates normally sub-threshold 
conditioning stimuli, but blocks the encoding of supra-threshold associative emotional 
memory. The question is what molecular mechanisms may underlie the ability of D4-
receptor activation within the PFC to potentiate the emotional salience of normally 
sub-threshold fear conditioning stimuli? More recent molecular evidence, to be 
described presently, linking D4-receptor activation with bidirectional modulation of α-
Ca2+/calmodulin-dependent protein kinase II (α-CaMKII), a molecule involved in 
synaptic plasticity, learning and memory (Malenka et al., 1999; Frankland et al., 
2001). These findings illustrate D4 receptor modulation of post-synaptic AMPA 
receptors localized on inhibitory PFC interneurons and pyramidal neurons (Yuen et 
al., 2009; Gu and Yan, 2004; Gu et al., 2006) may provide a compelling mechanism 




 Previous molecular studies performed in PFC slice preparations characterized 
an interesting bidirectional relationship between D4-receptor activation during high or 
low neuronal activity levels, and the resulting effect on CaMKII activity. Thus, Gu 
and Yan (2004) reported that in vitro slice preparations of rodent mPFC, D4-receptor 
activation strongly increases α-CaMKII activity through the stimulation of the 
phospholipase-C pathway and subsequent elevation of intracellular Ca2+ through 
ionsitol-1,4,5,-triphosphate receptors. Interestingly, this stimulatory effect of D4-
receptor activation on intracellular levels of CaMKII occurred only during low 
baseline levels of PFC neuronal activity. In contrast, during high levels of neuronal 
activity, D4 agonist application causes a marked decrease in α-CaMKII levels, an 
effect that was mediated through a protein kinase A, protein-phosphatase-1 dependent 
mechanism, demonstrating that D4 receptor signaling within the PFC bidirectionally 
modulates α-CaMKII activity as a function of baseline mPFC neuronal activity levels. 
Interestingly, in a follow-up study, Gu et al. (2006) reported that concomitant with 
D4-receptor activation induced upregulation of CaMKII, there was an increase in 
post-synaptic AMPA-receptor-mediated excitatory currents and increased surface 
expression of the GluR1 subunit of the AMPA receptor complex, within cultured PFC 
pyramidal neurons. These results are particularly interesting in the context of a more 
recent report, discussed previously, demonstrating that D4-receptor activation can 
specifically decrease AMPA-receptor expression associated with GABAergic 
interneurons within the PFC (Yuen et al., 2009). Indeed, these differential effects of 
D4-receptor activation upon PFC pyramidal neuron populations (increased AMPA-
receptor surface expression) versus inhibitory interneurons (decreased AMPA-
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receptor surface expression) provides a compelling mechanism whereby D4-receptor 
activation may shift neuronal network activity within the PFC towards decreased 
inhibitory influence and a concomitant potentiation of pyramidal neuron activity. 
Given the well established role of AMPA receptor transmission in various forms of 
synaptic plasticity related to learning and memory (Barria et al., 1997), such a 
functional interaction between D4 receptor transmission, CaMKII activity levels, and 
modulation of AMPA-receptor substrates localized to PFC pyramidal neurons 
suggests an interesting framework within which convergent inputs from DA terminals 
in the VTA and glutamatergic inputs from the BLA, may converge upon PFC neurons 
to control the encoding of emotionally salient learning and memory. 
 In Figure 1.3, we present a simplified schematic demonstrating how D4-
receptor-mediated modulation of CaMKII levels and AMPA-receptor transmission in 
the PFC may bidirectionally control the emotional salience of sensory information as 
a function of baseline activity levels of PFC neuronal populations. For the sake of 
simplicity, we have excluded the potential roles of D4-receptor-mediated modulation 
of NMDA receptors (Wang et al., 2003) and/or AMPA receptor substrates associated 
with PFC interneurons (Yuen et al., 2009), although these mechanisms, described 
previously, are equally compelling candidates. In this hypothetical model, we propose 
that during low levels of PFC activity (as would be predicted during the experience of 
normally non-emotionally salient sensory events), neuronal emotional memory 
encoding networks would be susceptible to disruptions in D4 receptor signaling (as 
may be present in disorders such as schizophrenia or ADHD), which in turn could 
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alter downstream regulation of CaMKII levels and/or the expression of AMPA 
receptor substrates within PFC pyramidal neurons. This could theoretically lead to a 
potentiation in the emotional salience and associative memory magnitude of inputs 
converging on PFC pyramidal neuron populations, as the relative magnitude of GLUT 
inputs from the BLA converging upon GLUT receptor substrates on PFC pyramidal 
neurons may be amplified by the effects of D4-receptor-mediated increases in 
CaMKII levels and the resulting increased expression of AMPA receptors on this 
neuronal population (Gu et al., 2006). This may lead to the formation of a 
maladaptive associative memory between that stimulus and its distorted emotional 
significance, as suggested by behavioural fear conditioning studies (Shah et al., 
2004). In contrast, during high levels of PFC baseline activity (as may be predicted 
during a highly salient emotional experience), DAergic inputs from the VTA, and 
GLUT inputs from the BLA would be increased. During high neuronal activity 
baseline, D4-receptor activation would be predicted to inhibit feedforward 
GABAergic inhibition on PFC pyramidal neurons, whereas D4 receptor activation on 
pyramidal neurons themselves would lead to a decrease in CaMKII signaling, and 
resulting decrease in surface expression of AMPA receptors on the PFC pyramidal 
neurons. Such a mechanism may lead to the blockade of appropriate associative 
memory formation, as suggested by behavioural and electrophysiological evidence in 






Figure 1.3 An alternative framework for PFC D4-receptor-mediated modulation of 
emotional processing based on molecular evidence demonstrating a role for PFC D4 
signaling in the control of CaMKII and AMPA-receptor function in PFC pyramidal 
neurons. 
In this hypothetical model, levels of CaMKII and AMPA-receptor expression levels in 
PFC pyramidal neurons are controlled by D4-receptor activation via VTA inputs. 
However, the effects of D4-receptor-mediated signaling on intra-neuronal CaMKII and 
AMPA-receptor modulation depends upon the existing baseline level of PFC neuronal 
activity: (A) in the presence of sensory input containing low levels of emotional salience, 
D4-receptor activation increases CaMKII levels, which in turn increases surface 
expression of AMPA receptors localized on PFC pyramidal neurons (Gu & Yan, 2004; 
Gu et al., 2006) theoretically potentiating the associative memory encoding of normally 
emotionally sub-threshold sensory inputs by amplifying the emotional memory encoding 
effects of DA and GLUT inputs from the VTA and BLA onto specific subpopulations of 
PFC neurons, as suggested by behavioural and molecular evidence (Gu et al., 2006). (B) 
In contrast, in the presence of sensory input containing high levels of emotional salience, 
D4-receptor activation decreases CaMKII activity levels and reduces the expression of 
AMPA-receptor substrates linked to associative GLUTergic inputs from the BLA, 
thereby attenuating the encoding of emotionally salient associative memory by 
decreasing the impact of GLUT and DA inputs from the BLA and VTA, respectively, 
again suggested by extant behavioural and molecular evidence (Gu et al., 2006). In either 
case, dysregulation of endogenous D4-receptor transmission within the PFC would be 
predicted to distort the emotional meaning and associative memory encoding of incoming 
sensory information, by either pathological amplification or dampening of the emotional 







 The apparent functional arrangement between D4 receptor mediated control of 
CaMKII within the PFC could account for many of the emotional processing 
abnormalities observed in complex disorders such as schizophrenia, ADHD, and 
addiction. Thus, hyperactive stimulation of PFC D4 receptor populations could 
amplify the emotional and/or motivational salience of normally non-salient sensory 
inputs, for example, environmental cues previously associated with drug taking that 
become pathologically relevant during states of psychostimulant addiction and trigger 
persistent drug seeking and relapse. Alternatively, olfactory, auditory, or visual cues, 
whether real or imagined, may gain distorted emotional significance in disorders such 
as schizophrenia , possibly leading to delusional thinking or psychotic ideation as 
these associations become pathologically encoded within the PFC over time. In 
contrast, given that D4 receptor activation appears to block encoding of emotionally 
salient associative memory in the presence of highly salient sensory cues (Laviolette 
et al., 2005) and can actively decrease levels of CaMKII within memory encoding 
neurons of the PFC (Gu and Yan, 2004), one potential consequence of this functional 
relationship would be an inability to form appropriate associative memories between 
sensory cues and their appropriate emotional meaning in the context of a highly 
salient emotional experience. 
1.4 SUMMARY AND RATIONALE 
The mPFC is well recognized as an important integrative centre for executive 
cognitive functioning and is crucial in the processing and filtering of emotionally 
relevant sensory information. Increasing evidence from genetic, behavioural, 
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electrophysiological, and molecular research endeavors points to important and 
unique roles for the DA D1 versus D4 receptor subtypes in the processing of 
emotionally salient information and modulation of learning and memory within the 
mPFC neural circuitry. The author proposes that DA transmission within PFC may 
exert a ‘bidirectional’ mode of action on PFC interneuron versus pyramidal neuron 
network activity with DA D1 and D4 receptors controlling activity of intrinsic, 
GABAergic circuit neurons. Such an arrangement is consistent with other studies 
suggesting that DA transmission is involved in regulating inhibitory influences within 
the PFC. The role of differential DA transmission within mPFC in controlling not 
only neuronal network activity within this area, but also in the different phases of 
learning; specifically, encoding and expression of associative emotional information 
within the mesocorticolimbic system - has important implications for a variety of 
neuropsychiatric syndromes. 
 A clearer understanding of the specific roles of DA D1 and D4 receptor 
transmission during emotional learning and memory may help elucidate how 
abnormalities in the mPFC neural circuitry may lead to aberrant emotional 
processing, learning, and memory in disorders such as schizophrenia, drug addiction, 
PTSD, and ADHD. Therefore, the overarching goal of our research project is to 
characterize the D1 and D4 receptor modulation of the functional interactions between 
the VTA, BLA, and the mPFC in the processing of emotionally salient sensory 
information and explore how perturbations in these systems may lead to inappropriate 
conditioned associations between sensory input and internal emotional states. 
  
37 
1.5 HYPOTHESIS  
DA differentially acts upon D1 and D4 receptors within the mPFC to modulate 
emotional associative learning and memory processes through distinct second 
messenger pathways, which in turn increase, or decrease pyramidal output activity.  
1.5.1 Objectives 
1. Investigate the specific roles of DA D1 versus D4 receptor activation during the 
encoding and recall phases of emotional learning and memory using an olfactory 
fear conditioning assay in rats. 
2. Investigate the potential role of D4 receptor–mediated control of emotional memory 
salience through intracellular signaling via CaMKII, cAMP/protein kinase A 
(PKA), and protein phosphatase-1 (PP1) signaling in the mPFC. 
3. Investigate the potential role of D1 receptor–mediated control of emotional memory 
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2.1 INTRODUCTION  
The ability to assign appropriate emotional significance to incoming sensory 
information is essential for normal cognitive function and adaptive behaviour. These 
psychological processes require prefrontal cortical mechanisms that allow accurate 
filtering of salient versus nonsalient sensory information. Disturbances in these 
processes may lead to the formation of inappropriately reinforced associative 
memories, maladaptive behaviours, and delusional ideation, all of which are typically 
present in schizophrenia-related psychoses. Within the mPFC, cognitive, emotional, 
and motivational processes are strongly modulated by DAergic transmission and, in 
particular, through signaling via the DA D1 and D4 receptor subtypes (Seamans et al., 
1998; Pezze et al., 2003; Laviolette et al., 2005; Onn et al., 2006).  
 DAergic modulation of mPFC neuronal networks is known to control the 
encoding of working memory and the temporal sequencing of behavioural output 
(Goldman-Rakic et al., 1989; Goldman-Rakic, 1995; Seamans et al., 1998). 
Functionally, DAergic transmission within the mPFC influences neuronal network 
activity in a biphasic manner, with D1 receptor activation increasing the intrinsic 
excitability of inhibitory GABAergic interneurons and D2-like receptor activation 
decreasing the activity of these interneurons, presumably leading to decreased 
probability of tonic inhibitory GABA release within the mPFC (Seamans et al., 2001). 
The D4 subtype is expressed highly in mPFC relative to other brain regions and plays 
a critical role in modulating neuronal activity in both prelimbic and infralimbic mPFC 
regions (Ceci et al., 1999; Onn et al., 2005). Additional support for a modulatory role 
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of DA D4 receptor transmission is suggested by findings that DA-mediated 
amplification of mPFC neuronal activity is preferentially mediated through DAergic 
actions on the D4 receptor subtype (Ceci et al., 1999). Given the critical role of the 
mPFC in the encoding and expression of emotionally salient information and its 
ability to amplify DAergic effects within mPFC neuronal networks, one possibility is 
that DA D4 receptor activation within the mPFC may amplify the emotional salience 
of sensory information and the subsequent encoding of this associative information.   
 A subpopulation of neurons within the mPFC is capable of encoding and 
expressing emotional conditioned associations via inputs from the basolateral nucleus 
of the amygdala (BLA) (Laviolette et al., 2005; Laviolette and Grace, 2006a, b). We 
have reported previously that D4 receptor blockade, either systemically or directly 
within the mPFC, can prevent the acquisition (but not expression) of emotionally 
salient associative fear memories, as demonstrated behaviourally and at the level of 
the single neuron (Laviolette et al., 2005). However, it is presently not known how 
activation of DA D4 versus D1 receptor transmission within the mPFC may be 
involved in modulating the acquisition and/or expression (recall) of emotionally 
salient information or how these receptors may modulate salient versus nonsalient 
sensory stimuli in the context of emotional memory encoding. Accordingly, we 
conducted a series of behavioural pharmacological studies comparing the potential 
roles of DA D4 versus D1 receptor transmission during the acquisition or expression 
phases of emotional learning and memory processing, by comparing emotionally 
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salient versus nonsalient associative conditioning stimuli during an olfactory fear-
conditioning procedure.  
2.2 MATERIALS AND METHODS 
2.2.1 Animals and surgery 
Male Sprague Dawley rats (300–350 g) were obtained from Charles River 
Laboratories. All procedures were performed in accordance with the Canadian 
Council on Animal Care and were approved by the Council on Animal Care at the 
University of Western Ontario. Rats were anesthetized with a ketamine (80 mg/ml)–
xylazine (6 mg/kg) mixture administered intraperitoneally and placed in a stereotaxic 
device. All stereotaxic coordinates were based on the atlas of Paxinos and Watson 
(1996). Two stainless steel guide cannulae (22 gauge) were implanted into the mPFC 
using the following stereotaxic coordinates (15° angle; in millimeters from bregma): 
anteroposterior (AP), +2.9; lateral (LAT), ±1.9; ventral (V), −3.0 from the dural 
surface. For bilateral intra-BLA placements, the following stereotaxic coordinates 
were used (0° angle): AP, −3.0; LAT, ±5.0; V, −8.0 from the dural surface (see Fig. 
2.4). Jeweler's screws and dental acrylic were used to secure the cannulae. 
2.2.2 Olfactory fear conditioning  
Rats were taken from their home cages, received sham microinfusions into the mPFC, 
and were habituated for 30 min in a ventilated conditioning chamber with an electric 
grid floor inside a sound-attenuated room. Olfactory fear conditioning took place in 
one of two distinct environments, counterbalanced within groups: “shock” 
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environment A was a 30 × 30 inch Plexiglas box with black stripes on a white 
background and a metallic grid shock floor, whereas shock environment B was a 30 × 
30 inch Plexiglas box with black dots on a white background with a grid shock floor. 
Testing 24 h later took place in one of two alternate environments, in which animals 
had not previously received electric shock, counterbalanced within groups: test 
environment A had walls with black dots and a gray Plexiglas floor, whereas test 
environment B had walls with black and white stripes and a gray Plexiglas floor. On 
day 1 (habituation phase), animals were habituated to a random combination of shock 
environment A or B and test environment A or B in a counterbalanced order for 30 
min in each environment. On day 2 (conditioning phase), animals were returned to the 
conditioning room and placed in the previously assigned shock environment. During 
the conditioning phase, one of the odours (almond or peppermint) was presented to 
the animal for 19 s, and a footshock was then delivered (0.4 or 0.8 mA) for 1 s 
[positive conditioned stimulus (CS+)]. The two different levels of footshock (0.4 and 
0.8 mA) correspond to subthreshold and suprathreshold levels of emotional stimuli, as 
reported previously (Laviolette and Grace, 2006a). One hundred twenty seconds later, 
the alternate odour was presented for 20 s [negative conditioned stimulus (CS−)] in 
the absence of footshock. This cycle was repeated five times. On the following day 
(test phase), rats were returned to the test room and placed in the previously assigned 
test environment. Before odour presentation, the rat was allowed to explore the 
environment for 1 min, during which time baseline levels of freezing and exploratory 
behaviour were observed. Odours (CS+ or CS−) were then presented for 5 min each 
to the animal in a counterbalanced order, and the amount of time freezing was 
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recorded. Freezing was defined as complete immobility with the exception of 
respiratory-related movement. We also analyzed exploratory behaviour in response to 
presentations of CS+ or CS− odours, as described previously (Rosenkranz and Grace, 
2003). Exploratory behaviour was scored as follows, with a score assigned for every 
minute of each of the 5 min during the CS+ or CS− odour presentations: 0, no 
locomotion; 1, ambulation across one side of the testing chamber; 2, ambulation 
across two sides; 3, exploration of the full perimeter of the testing chamber; 4, 
exploration of the center and entire perimeter of the test chamber. To analyze DA 
receptor modulation on acquisition of emotionally salient information, microinfusions 
were given directly before the conditioning procedure. To examine the effects of DA 
receptor manipulation on the expression phase of learned emotional memory drug, 
microinfusions were given directly before testing (24 h after fear conditioning). 
Experimental procedures for examining acquisition (encoding) versus expression 
(recall) of associative fear conditioning are summarized schematically in Figure 2.1C. 
2.2.3 Drug administration 
For mPFC and BLA microinfusions, stainless steel guide cannulae (22 gauge) were 
implanted bilaterally into the mPFC or BLA, and drugs were administered through a 
28 gauge microinfusion injector (Plastics One). All drugs were dissolved in 
physiological saline, with pH adjusted to 7.4. Bilateral intra-mPFC microinjection of 
saline vehicle, the highly selective D4 agonist PD 168077 (dose range, 2.5–50 ng/0.5 
µl; Tocris), the D1-like receptor agonist SKF 38393 (dose range, 100–1000 ng/0.5 µl; 
Sigma), the D2-like agonist quinpirole (dose range, 100–1000 ng/0.5 µl; Sigma), or 
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the D4 antagonist L-741,741 (1000 ng; Tocris) and the full D1 receptor agonist SKF 
81297 (dose range, 1–100 ng/0.5 µl; Tocris) were microinfused immediately before 
the olfactory conditioning procedure (acquisition phase challenge) or immediately 
before the testing phase (recall challenge). For studies examining the role of BLA 
inputs, bilateral intra-BLA microinjections of either saline vehicle or muscimol (500 
ng/0.5 µl) were performed immediately before intra-mPFC PD 168077 (50 mg/0.5 µl) 
microinjections. 
2.2.4 Footshock sensitivity analysis 
To determine whether our intra-mPFC pharmacological manipulations induced 
alterations in sensitivity to footshock, we rigorously monitored behavioural responses 
to these manipulations before and after drug administration. For intra-mPFC 
experiments, we performed separate control experiments, wherein animals received 
either bilateral intra-mPFC saline (control) or the D4 agonist PD 186077 (50 ng/0.5 
µl) and were placed in a clear Plexiglas environment with a footshock grid floor. 
Based on previously published methodology (Laviolette and Grace, 2006), we 
presented either a behaviourally subthreshold footshock level (0.4 mA, 1 s) or a 
behaviourally suprathreshold footshock level (0.8 mA) over five times and measured 
sensitivity to footshock over four separate variables: (1) percentage of time spent 
freezing in 20 s postfootshock intervals; (2) number of jumps in response to 
footshock; (3) amount of defecation (in pieces) during footshock session; and (4) 
number of times the animal reared during the sensitivity trial. All of these behavioural 
indices of footshock sensitivity have been reported as reliable indicators of fear 
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reactivity to the presentation of a footshock stimulus (Antoniadis and McDonald, 
1999). 
2.2.5 Histology 
After completion of the experiment, the animals were perfused, and brains were 
removed and stored in formalin with 25% sucrose solution for at least 24 h. Brains 
were then sectioned into 40 µm coronal slices, mounted, and stained using cresyl 
violet to allow for histological analysis of the site of injection. The majority of mPFC 
placements were localized within the boundaries of the prelimbic cortical area (PLC). 
2.2.6 Data analysis 
Data were analyzed with one-, two-, or three-way ANOVA where appropriate or 
Student's t tests. Post hoc analyses were performed with Newman–Keuls tests. 
2.3 RESULTS 
2.3.1 Intra-mPFC histological analysis 
Histological analysis revealed microinfusion injector cannulae placements to be 
bilaterally localized within the anatomical boundaries of the mPFC region, as 
determined by the atlas of Paxinos and Watson (1996). In Figure 2.1A, we present a 
microphotograph showing a typical, representative injector placement within the 
mPFC. In Figure 2.1B, we present a schematic illustration showing representative 
intra-mPFC bilateral cannulae placements along the rostrocaudal axis of the mPFC. 
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2.3.2 Intra-mPFC DA receptor activation potentiates associative 
learning to emotionally nonsalient conditioning stimuli 
For this and all subsequent behavioural experiments, we present a schematic 
illustration in Figure 2.2A, showing our fear-conditioning procedure in terms of 
conditioning timelines and methods for challenging either the acquisition (encoding 
phase) or the expression (recall phase) of emotional associative learning. To establish 
salient versus nonsalient levels of footshock for use in our fear-conditioning 
procedures, we selected two levels of footshock (0.4 and 0.8 mA) for use in our 
olfactory fear-conditioning procedures, based on a previously published report 
(Laviolette and Grace, 2006). Preliminary studies determined that whereas the lower 
level of footshock (0.4 mA; n = 5) (Fig. 2.2B) produced no significant associative 
memory encoding (animals demonstrated no conditioned freezing behaviour in 
response to CS+ relative to CS− presentations; t(4) = 0.15; p > 0.05), a higher level of 
footshock (0.8 mA; n = 6) (Fig. 2.2B) produced strong associative fear conditioning, 
demonstrated by significantly greater levels of conditioned freezing in response to 
CS+ relative to CS− presentations (t(5) = 5.84; p < 0.01). Similarly, whereas the lower 
level of footshock (0.4 mA; n = 5) produced no associative suppression of exploratory 
behaviour in response to CS+ versus CS− presentations (Fig. 2C) (t(4) = 1.78; p > 
0.05), a higher level of footshock (0.8 mA; n = 6) (Fig. 2.2B) produced conditioned 
suppression of exploratory behaviour specifically in response to CS+ relative to CS− 






Figure 2.1 Histological analysis of intra-mPFC microinjection sites.  
(A) Microphotograph of a representative injector placement within the mPFC. (B) 
Schematic illustration showing representative bilateral placements of microinjection 
cannulae. For illustrative clarity, only a subset of experimental groups is presented. 
Symbols represent separate experimental groups: ▵, PD 168077, 50 ng/0.5 µl versus 
acquisition of subthreshold stimuli; □, SKF 38393, 1000 ng/0.5 µl versus acquisition of 
subthreshold stimuli; ▾, PD 168077, 50 ng/0.5 µl versus acquisition of suprathreshold 






Figure 2.2 Experimental protocol summary and footshock sensitivity level assay.  
(A) Schematic representation showing experimental associative fear conditioning assay 
and timeline for examining acquisition (encoding) versus expression (recall) phases of 
associative olfactory fear memory. (B, C) Behavioural sensitivity assay demonstrating 
that although subthreshold (0.4 mA) footshock stimuli produce neither conditioned 
freezing behaviour (B) nor conditioned suppression of exploratory behaviour (C), 
presentation of a suprathreshold (0.8 mA) footshock level produces significant levels of 
freezing (B) and suppression of exploratory behaviour (C). Error bars represent SEM for 
this and all subsequent figures. For this and all subsequent figures, *p < 0.05; **p < 0.01. 
  
62 
 Thus, similar to previous reports (Laviolette et al., 2005; Laviolette and Grace, 
2006a), these levels of footshock were selected for subsequent experiments to 
represent “salient” versus “nonsalient” emotional conditioning stimuli. Using our 
associative olfactory fear-conditioning procedure (see Materials and Methods) 
(Laviolette et al., 2005; Laviolette and Grace, 2006a) with an emotionally nonsalient 
(0.4 mA) level of footshock (which produces no associative fear conditioning in 
control animals) (Laviolette and Grace, 2006a), we next performed bilateral intra-
mPFC microinfusions of either saline or the specific DA D4 agonist PD 168077 (2.5, 
25, or 50 ng/0.5 µl) immediately before fear conditioning, to determine the effects of 
D4 receptor activation during the acquisition phase (encoding) of this associative 
information. ANOVA revealed a significant interaction between group and treatment 
(F(3,53) = 11.2; p < 0.001) on times spent freezing to either CS+ or CS− cue 
presentations at testing. Post hoc analysis illustrated a dose-dependent potentiation in 
associative fear-conditioning expression at the two higher doses of PD 168077, 25 ng 
(n = 7; p < 0.05) and 50 ng (n = 8; p < 0.01), demonstrated by a significantly greater 
time spent freezing to the CS+ compared with CS− (Fig. 2.3A). In contrast, post hoc 
analysis revealed no significant difference between freezing time to the CS+ 
compared with CS− for the saline (n = 5; p > 0.05) control group or animals receiving 
the lowest dose of PD 168077 (2.5 ng/0.5 µl; n = 7; p > 0.05).  
 To demonstrate the receptor specificity of our D4 agonist effect, we performed 
a separate control experiment (n = 7) wherein rats received co-infusion of the highest 
effective dose of PD 168077 (50 ng/0.5 µl) with a competitive antagonist of the D4 
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receptor, L-741,741 (1000 ng/0.5 µl), before subthreshold olfactory fear conditioning. 
Statistical analysis revealed that D4 antagonist co-administration blocked the 
potentiating effect of PD 168077 because rats showed no significant difference 
between percentage of time spent freezing (t(6) = 1.22; p > 0.05) in response to the 
CS+ relative to the CS− (Fig. 2.3A). Analysis of spontaneous exploratory behaviour 
during presentations of either CS+ or CS− (Fig. 2.3B) revealed a significant 
interaction between group and treatment (F(3,63) = 2.57; p < 0.01) with post hoc 
analysis revealing that rats treated with the highest dose PD 169077 (50 ng/0.5 µl; n = 
8) or 25 ng/0.5 µl (n = 6) displayed significantly decreased exploratory behaviour in 
response to the CS+ relative to the CS− presentations (p < 0.01 and p < 0.05, 
respectively). In addition, post hoc analysis revealed there was no significant 
difference in exploratory behaviour observed in response to the CS+ relative to the 
CS− with the lower doses of PD 168077, 2.5 ng/0.05 µl (n = 7; p > 0.05) and 25 
ng/0.5 µl (n = 7; p > 0.05), as well as the saline control group (n = 5; p > 0.05) (Fig. 
2.3B). In addition, in the pharmacological control group receiving co-administration 
of PD 168077 (50 ng/0.5 µl) with the D4 antagonist L-741,741 (1000 ng/0.5 µl) 
demonstrated no significant difference between exploratory behaviour in response to 
the CS+ and CS− presentations (t(6) = 1.05; p > 0.05) (Fig. 2.3B).  
 To further characterize the specific role of the DA D4 subtype relative to other 
D2-like receptors within the mPFC in our observed emotional associative learning 
potentiation effects, we ran an additional control experiment using a nonspecific 
agonist of D2-like receptors, quinpirole, with relative Ki values of 4.8, ∼24, ∼30, and 
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∼1900 nm at the D2, D3, D4, and D1 DA receptor subtypes, respectively (Seeman and 
Van Tol, 1994; Levant et al., 1996), for comparison with the effects of the specific D4 
receptor agonist PD 168077 (Fig. 2.3A). We performed bilateral intra-mPFC 
microinfusions of quinpirole, immediately before conditioning, at two different 
concentrations: a lower concentration (100 ng/0.5 µl), which should display greater 
selectivity for the D2 receptor subtype, and a higher concentration (1000 ng/0.5 µl), 
which would not provide specificity at the D2 receptor but, rather, likely interact with 
all D2-like subtypes, including the D4 receptors. ANOVA revealed a significant effect 
of treatment on time spent freezing (Fig. 2.3C) (F(2, 33) = 5.6; p < 0.01). Post hoc 
analysis revealed no significant difference in the time spent freezing to the CS+ 
relative to the CS− in rats receiving a lower, D2 receptor-specific dose of quinpirole 
(n = 6; p > 0.05). In contrast, post hoc analysis revealed that intra-mPFC 
microinfusions of quinpirole at the higher (nonspecific) dose (1000 ng/0.5 µl) resulted 
in a potentiation of subthreshold fear stimuli as demonstrated by a significant increase 
in the time spent freezing to the CS+ relative to the CS− (n = 6; p < 0.01) (Fig. 2.3C).  
 Whereas it is not possible to directly compare in vitro binding kinetics with 
that which would be observed in vivo, these results demonstrate the DA activation 
within the mPFC specifically potentiates emotional associative learning via actions on 
a highly sensitive D4 receptor population (showing emotional learning potentiation at 
doses as low as 25 ng/0.5 ml (Fig. 2.3A) rather than via nonspecific effects on all D2-





Figure 2.3 Bilateral intra-mPFC DA D4 and D2 receptor manipulations versus 
subthreshold levels of fear-conditioning stimuli.  
(A) Bilateral intra-mPFC microinfusions of the DA D4 receptor agonist PD 168077 (2.5, 
25, and 50 ng/0.5 µl) dose-dependently potentiated the acquisition of subthreshold (0.4 
mA footshock) olfactory fear conditioning. Both saline controls and rats receiving a 
lower dose of PD 168077 (2.5 ng/0.5 µl) display no significant difference in time freezing 
to the CS+ relative to the CS− presentations. In contrast, rats receiving higher doses of 
PD 168077 (25 ng and 50 ng/0.5 µl) display significantly greater levels of freezing 
specifically in response to presentation of the CS+ relative to CS−. In a separate control 
experiment, this D4 receptor-induced potentiation was blocked when the D4 receptor 
antagonist L-741,741 (1000 ng/0.5 µl) was coadministered with PD 168077 (50 ng/0.5 
µl), as rats display no significant difference in conditioned freezing behaviour in response 
to the CS+ relative to CS− presentations. (B) Measurement of exploratory behaviour in 
response to the CS+ and CS− odours revealed saline control rats and rats receiving the 
lower two doses of PD 168077 (2.5 and 25 ng/0.5 µl) showed no significant difference in 
exploratory scores. However, with the 50 ng/0.5 µl PD 168077 dose, there was a 
significant decrease in spontaneous exploratory behaviour after CS+ relative to CS− 
presentation. Similarly, intra-mPFC coadministration with the D4 receptor antagonist L-
741,741 (1000 ng/0.5 µl) with PD 168077 (50 ng/0.5 µl) blocked conditioned suppression 
of exploratory behaviour, demonstrated by no significant difference between exploratory 
behaviour in response to CS+ and CS− presentations. (C) Bilateral intra-mPFC 
microinfusions of the D2-like receptor agonist quinpirole failed to potentiate subthreshold 
fear-conditioning acquisition at a lower dose of 100 ng/0.5 µl, demonstrated by no 
significant freezing response to CS+ versus CS− presentations. However, bilateral intra-
mPFC microinfusions of quinpirole at a higher (nonspecific) dose (1000 ng/0.5 µl) 
resulted in a potentiation of subthreshold fear stimuli as demonstrated by a significant 






These behavioural results are consistent with anatomical and electrophysiological 
evidence showing higher relative concentrations of the D4 subtype and greater 
neuronal sensitivity within the mPFC to DA D4 receptor activation, relative to other 
DA receptor subtypes (Mrzljak et al., 1996; Ceci et al., 1999; Wedzony et al., 2000; 
Onn et al., 2005). 
2.3.3 Intra-mPFC DA D4 receptor activation blocks the encoding 
but not the expression of associative learning to emotionally 
salient conditioning stimuli  
We next examined the possible effects of mPFC DA D4 activation on the encoding of 
suprathreshold fear-conditioning stimuli, using a higher, emotionally salient dose of 
footshock (0.8 mA). We first examined the acquisition phase of emotional learning by 
administering an effective dose of the D4 agonist (50 ng/0.5 µl) immediately before 
conditioning. A control group (n = 7) receiving intra-mPFC saline before fear 
conditioning to the suprathreshold footshock level showed significant levels of 
conditioned fear at testing, demonstrated by a significant increase both in freezing 
behaviour (n = 7; t(6) = 4.29; p < 0.01) (Fig. 2.4A) and a decrease in exploratory 
behaviour (n = 7; t(6) = 3.45; p < 0.05) (Fig. 2.4B) in response to the CS+ presentation 
relative to the CS−. In contrast, rats receiving bilateral intra-mPFC microinfusions of 
the effective dose of PD 168077 (n = 8; 50 ng/0.5 µl) demonstrated a complete block 
in the acquisition of emotionally salient fear stimuli as demonstrated by no significant 
difference in response to CS+ versus CS− presentations in either freezing behaviour 
(t(7) = 1.14; p > 0.05) (Fig. 2.4A) or exploratory behaviour (t(7) = 1.15; p > 0.05) (Fig. 
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2.4B). Thus, activation of mPFC D4 receptors blocked the encoding of emotional 
associative learning to a suprathreshold, emotionally salient footshock stimulus.  
 We next examined the expression phase of emotional learning by performing 
bilateral intra-mPFC microinfusions of the D4 agonist (n = 8; 50 ng/0.5 µl) 
immediately before the testing (recall phase; 24 h after conditioning). Analysis 
revealed intra-mPFC PD 168077 (50 ng/0.5 µl) did not block the expression of 
previously learned emotionally salient information as demonstrated by a significant 
increase in the percentage of time spent freezing to the CS+ relative to the CS− (t(7) = 
3.03; p < 0.05) (Fig. 2.4A), as well as a significant decrease in the exploratory 
behaviour observed in response to the CS+ relative to the CS− presentations (t(7) = 
3.46; p < 0.05) (Fig. 2.4B). Thus, activation of intra-mPFC DA D4 receptors 
specifically blocks the encoding of emotionally salient associative learning, while 
having no effect on the expression (recall) of this information. 
2.3.4 Footshock sensitivity analysis 
Although no existing evidence supports a modulatory role for mPFC DA D4 receptor 
transmission in the processing of nociceptive information, an alternative explanation 
for our observed conditioning effects on potentiation of subthreshold (0.4 mA) 
emotional fear conditioning or blockade of the acquisition of suprathreshold (0.8 mA) 
footshock presentations may be a D4 receptor-mediated increase or decrease in 
peripheral nociceptive sensitivity to footshock presentations. To rule out this 
possibility, we analyzed behavioural sensitivity to our low footshock level (0.4 mA), 
comparing rats receiving microinfusions of either saline (n = 5) or the effective dose 
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of the D4 agonist PD 168077 (n = 5; 50 ng/0.5 µl). In addition, we analyzed 
behavioural sensitivity to our higher, suprathreshold level of footshock (0.8 mA) 
comparing rats receiving microinfusions of either saline (n = 6) or the effective dose 
of the D4 agonist PD 168077 (n = 6; 50 ng/0.5 µl). 
 We compared physiological and behavioural reactions to footshock 
presentations as described previously (see Materials and Methods) (Laviolette and 
Grace, 2006a). For control groups receiving the subthreshold footshock presentations 
(0.4 mA), comparing saline control versus intra-mPFC PD 168077 pretreated groups 
revealed no significant differences in footshock-induced freezing behaviour (t(4) = 
0.28; p > 0.5) (Fig. 2.4C). Furthermore, no significant differences were observed in 
the number of rears between groups in response to footshock (t(4) = 1.29; p > 0.05) 
(Fig. 2.4D), in the quantity of footshock-related jumping between groups (t(4) = 0.20; 
p > 0.5) (Fig. 2.4E), and for defecation between groups during the footshock 
presentation session (t(4) = 0.23; p > 0.05) (Fig. 2.4F). For control groups receiving 
the suprathreshold footshock presentations (0.8 mA), comparing saline control versus 
intra-mPFC PD 168077 pretreated groups revealed no significant differences in 
footshock-induced freezing behaviour (t(5) = 0.88; p > 0.5) (Fig. 2.4C). Furthermore, 
no significant differences were observed in the number of rears between groups in 
response to footshock (t(5) = 0.92; p > 0.05) (Fig. 2.4D), in the quantity of footshock-
related jumping between groups (t(5) = 0.23; p > 0.5) (Fig. 2.4E), and in the amount of 
defecation between groups during the footshock presentation session (t(5) = 0.18; p > 




Figure 2.4 Intra-mPFC D4 agonist effects on suprathreshold olfactory fear 
conditioning and footshock sensitivity analyses.  
(A) Saline control rats showed significant freezing behaviour to CS+ versus CS− 
presentations after conditioning with suprathreshold footshock (0.8 mA) levels. In 
contrast, preconditioning microinfusion of intra-mPFC PD 168077 (50 ng/0.5 µl) blocked 
the acquisition of suprathreshold olfactory fear conditioning as demonstrated by no 
significant difference in the percentage of time spent freezing to the CS+ relative to the 
CS− at testing. However, intra-mPFC PD 168077 (50 ng/0.5 µl) microinfusions 
immediately before testing did not block the expression (recall) of suprathreshold 
olfactory fear conditioning. (B) Analysis of exploratory activity after CS+ or CS− 
presentation revealed that whereas saline control rats showed significant conditioned 
suppression of exploratory behaviour in response to CS+ versus CS− presentations, this 
effect was blocked in rats receiving intra-mPFC PD 168077 (50 ng/0.5 µl) immediately 
before conditioning. In contrast, intra-mPFC PD 168077 (50 ng/0.5 µl) administered 
immediately before testing did not block the expression (recall) of suprathreshold 
olfactory fear conditioning observed as a significant decrease in exploratory behaviour in 
response to CS+ presentations. (C) Footshock sensitivity testing (see Materials and 
Methods) revealed no significant differences between control groups receiving a 
subthreshold footshock (0.4 mA) versus intra-mPFC saline control (n = 5) or intra-mPFC 
PD 168077 (50 ng/µl; n = 5) or between control groups receiving a suprathreshold level 
of footshock (0.8 mA) versus intra-mPFC saline control (n = 6) or intra-mPFC PD 
168077 (50 ng/µl, n = 6) in the percentage of time spent freezing in response to footshock 
presentations. (D) Similarly, no significant differences were observed in the mean 
number of rears between groups in response to either level of footshock. (E) No 
significant differences were observed between the mean numbers of jumps between 
groups in response to either level of footshock. (F) No significant differences were 







 These behavioural and physiological indices are well established correlates of 
footshock-related sensitivity (Antoniadis and McDonald, 1999; Laviolette and Grace, 
2006a) and demonstrate that activation of DA D4 receptors with the highest effective 
dose of intra-mPFC PD 168077 (50 ng/0.5 µl) does not produce any appreciable 
alterations in physiological/peripheral sensitivity to subthreshold (0.4 mA) or 
suprathreshold (0.8 mA) footshock presentations. In addition, because the present 
studies used a context-independent form of associative emotional memory 
conditioning, our observed effects are not likely related to any effects of DA D1 or D4 
modulation of spatial memory processing, as emotional associative memory encoding 
was linked specifically to olfactory cues, independent of spatial/environmental 
context, further underscoring the importance of DA D1 and D4 transmission during the 
encoding, modulation, and expression of associative learning and memory, 
specifically in the context of emotionally salient experience. 
2.3.5 D4 receptor mediated potentiation of emotional learning in 
the mPFC is dependent on the BLA 
We have reported previously that a subpopulation of neurons within the mPFC that 
receive a direct, functional input from the BLA, encode, and express emotional 
associative learning (Laviolette et al., 2005; Laviolette and Grace, 2006a). Indeed, 
pharmacological inactivation of the BLA before single neuron associative 
conditioning in the mPFC blocks the encoding of this information (Laviolette et al., 
2005; Laviolette and Grace, 2006a). To examine the potential role of the BLA in our 
observed potentiation of emotional learning via D4 receptor activation within the 
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mPFC, we examined the effects of pharmacological inactivation of the BLA before 
administration of intra-mPFC PD68077 (50 ng/0.5 µl) using a subthreshold level of 
footshock as the conditioning cue (0.4 mA). Bilateral microinfusions of the GABAA 
receptor agonist muscimol (n = 7; 500 ng/0.5 µl) or saline (n = 7) were performed in 
the BLA, immediately before intra-mPFC D4 agonist microinfusions. Histological 
analysis confirmed the placement of intra-amygdala cannulae within the anatomical 
boundaries of the BLA (Fig. 2.5A–C). Analysis revealed that intra-BLA muscimol 
pretreatment (500 ng/0.5 µl) significantly blocked the effects of intra-mPFC 
microinfusions of PD 168077 (50 ng/0.5 µl) as demonstrated by no significant 
difference in the percentages of time spent freezing (n = 7; t(6) = 0.31; p > 0.05) (Fig. 
2.5D) or exploratory behaviour (n = 7; t(6) = 0.31; p > 0.05) (Fig. 2.5E) in response to 
the CS+ versus CS− presentations, compared with saline control groups. Thus, the 
ability of mPFC D4 receptor activation to potentiate subthreshold emotional 
associative learning is dependent on the BLA, suggesting an important role for 
BLA>mPFC inputs in the processing of emotional learning and memory within the 
mPFC, as reported previously (Laviolette et al., 2005; Laviolette and Grace, 2006a). 
2.3.6 Effects of intra-mPFC DA D1 receptor activation on the 
encoding of nonsalient versus salient emotional stimuli 
during associative fear conditioning  
We next examined the potential role of mPFC DA D1 receptor transmission during 
the encoding of emotionally nonsalient sensory information, by performing bilateral 
microinfusions of the DA D1-like agonists (SKF 38393; 100 and 1000 ng/0.5 µl) or 
SKF 81297 (100 ng/0.5 µl) before conditioning rats with our subthreshold level of 
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footshock (0.4 mA). Initial pilot studies revealed that doses of intra-mPFC SKF 
81297 higher than 100 ng/0.5 µl produced seizures and/or aversive reactions in some 
animals; hence, 100 ng was the highest dose of this compound used for this and all 
subsequent experiments. For experiments using SKF 38393, ANOVA revealed no 
significant effect of treatment or group (F(2,33) = 0.68; p > 0.05) on the acquisition of 
subthreshold fear conditioning as demonstrated by no significant difference in the 
time spent freezing (n = 6, 100 ng/0.5 µl; n = 6, 1000 ng/0.5 µl; p > 0.05) (Fig. 2.6A) 
or exploratory behaviour (F(2,33) = 0.97; p > 0.05; n = 6, 100 ng/0.5 µl; n = 6, 1000 
ng/0.5 µl; p > 0.05) (Fig. 2.6B) in response to the CS+ compared with CS− 
presentations. 
 Given that intra-mPFC D1 receptor activation had no observable effect on fear 
conditioning to subthreshold (emotionally nonsalient) levels of footshock, we next 
investigated the possible role of D1 receptor activation on the acquisition of 
suprathreshold (emotionally salient levels of footshock; 0.8 mA). Rats received either 
bilateral microinfusions of intra-mPFC SKF 38393 (n = 8; 1000 ng/0.5 µl) or saline, 
immediately before olfactory fear conditioning with the suprathreshold footshock 
stimulus. ANOVA revealed a significant main effect of treatment on the percentage 
of time spent freezing in response to CS+ versus CS− presentations (F(1,25) = 83.2; p < 
0.0001) with post hoc analysis revealing that both SKF 38393 and saline pretreated 
groups displayed significantly greater amounts of freezing to the CS+, relative to CS− 






Figure 2.5 Histological analysis of intra-BLA cannulae placements and effects of 
BLA inactivation on D4-mediated emotional associative learning potentiation. 
(A) A microphotograph of a coronal section of the BLA showing a representative 
microinjection site (arrows). (B) Microphotograph of the BLA at higher magnification 
with a superimposed outline of the anatomical boundaries of the BLA relative to the 
adjacent central nucleus of the amygdala (CeA). (C) Representative schematic diagram 
showing representative intra-BLA microinjection sites: ▵, BLA saline control placements; 
•, intra-BLA muscimol (500 ng/0.5 µl) injector locations. (D) Intra-BLA saline 
administration before intra-mPFC PD 168077 (50 ng/0.5 µl) had no significant effect on 
the ability of mPFC D4 receptor activation to potentiate subthreshold (0.4 mA) olfactory 
fear-conditioning freezing behaviour, as rats displayed significant levels of freezing after 
CS+ presentations. Intra-BLA muscimol administration (500 ng/0.5 µl) before intra-
mPFC PD 168077 (50 ng/0.5 µl) significantly blocked the ability of mPFC D4 receptor 
activation to potentiate subthreshold olfactory fear conditioning, as rats displayed no 
differences in freezing behaviour to CS+ versus CS− presentations. (E) Similar to the 
effects observed with freezing behaviour, intra-BLA saline did not affect the ability of 
intra-mPFC D4 activation to potentiate emotional associative learning, as rats showed 
significantly greater conditioned suppression of exploratory behaviour in response to 
CS+ relative to CS− presentations. In contrast, this associative response was blocked in 







 Analysis of spontaneous exploratory behaviour revealed a significant group by 
treatment interaction on mean exploratory behaviour scores after CS+ versus CS− 
presentations (F(1,25) = 3.8; p < 0.01), with post hoc analysis revealing that both SKF 
38393 and saline pretreated groups displayed significantly attenuated exploratory 
behaviour in response to CS+ versus CS− presentations (Fig. 2.6D) (p < 0.01). 
2.3.7 Effects of intra-mPFC DA D1 receptor activation on the 
expression (recall) of emotionally salient associative fear 
conditioning  
Given that intra-mPFC D1 receptor activation produced no observable effects on the 
encoding of emotional associative learning using a nonsalient or salient footshock 
stimuli (Fig. 2.6), we next examined the potential role of mPFC D1 receptor 
transmission on the expression (recall) phase of emotional associative learning, using 
a suprathreshold, emotionally salient level of footshock (see Materials and Methods) 
as the conditioning stimulus. We administered either intra-mPFC SKF 38393 (100 
and 1000 ng/0.5 µl) or the full D1 receptor agonist SKF 81297 (1–100 ng/0.5 µl) 
directly before the testing phase of olfactory fear conditioning (24 h after 
conditioning). For experiments using SKF 38393, ANOVA revealed an interaction 
between treatment and group (F(3, 50) = 5.81; p < 0.01). Post hoc analysis revealed that 
rats pretreated with either saline (n = 8) or a lower dose of SKF 38393 (10 ng/0.5 µl) 
demonstrated significant fear conditioning at testing, with greater amounts of time 






Figure 2.6 Behavioural effects of bilateral intra-mPFC DA D1 receptor activation on 
the acquisition of salient or nonsalient associative fear conditioning memory.  
(A) Intra-mPFC DA D1 agonist SKF 38393 (100 and 1000 ng/0.5 µl; n = 7 and n = 8, 
respectively) had no effect on the percentage of time spent freezing to CS+ versus CS− 
presentations after olfactory fear conditioning with subthreshold footshock levels (0.4 
mA). Bilateral intra-mPFC administration of another D1 receptor agonist, SKF 81297 
(100 ng/0.5 µl), similarly had no effect on conditioning to a subthreshold level of 
footshock. (B) Intra-mPFC SKF 38393 (100 and 1000 ng/0.5 µl) had no effect on mean 
exploratory scores after CS+ versus CS− presentations after olfactory fear conditioning 
with subthreshold footshock stimuli. Bilateral intra-mPFC administration of the D1 
receptor agonist SKF 81297 (100 ng/0.5 µl) similarly had no effect on exploratory scores 
after CS+ or CS− presentations when conditioned with this subthreshold footshock level. 
(C) Intra-mPFC saline control and intra-mPFC SKF 38393 (1000 ng/0.5 µl) groups 
displayed a significant increase in freezing in response to CS+ versus CS− presentations 
after fear conditioning with suprathreshold footshock levels (0.8 mA). (D) In addition, 
intra-mPFC saline control and intra-mPFC SKF 38393 (1000 ng/0.5 µl) groups displayed 
a significant decrease in exploratory behaviour in response to CS+ versus CS− 






 In contrast, higher doses of intra-mPFC SKF 38393 produced a complete 
block of associative emotional memory recall, demonstrated by no significant 
difference in times spent freezing to CS+ versus CS− presentations (100 ng/0.5 µl, n = 
7; 1000 ng/0.5 µl, n = 8; p > 0.05) (Fig. 2.7A). Analysis of exploratory behaviour 
revealed a significant interaction between group and treatment (F(3,57) = 3.71; p < 
0.01) with post hoc analysis revealing that groups treated with saline (n = 8) or a 
lower dose of SKF 38393 (n = 8; 10 ng/0.5 µl) displayed significant conditioned 
suppression of exploratory behaviour in response to CS+ versus CS− presentations (p 
< 0.05), whereas this effect was blocked in groups receiving the higher doses of intra-
mPFC SKF 38393 (100 ng/0.5 µl, n = 7; 1000 ng/0.5 µl, n = 8; p > 0.05) (Fig. 2.7B) 
in response to CS+ versus CS− presentations. For experiments using SKF 81297 (1–
100 ng/0.5 µl), ANOVA revealed an interaction between treatment and group (F(3, 59) 
= 6.4; p < 0.001). Post hoc analysis revealed that rats pretreated with either saline (n = 
6) or the lower doses of SKF 81297 (1 or 10 ng/0.5 µl; n = 8 for both groups) 
demonstrated significant fear conditioning at testing, with greater amounts of time 
spent freezing to CS+ relative to CS− presentations (p < 0.01). In contrast, higher 
doses of intra-mPFC SKF 81297 (100 ng/0.5 µl) produced a complete block of 
associative emotional memory recall, demonstrated by no significant difference in 
times spent freezing to CS+ versus CS− presentations (n = 8; p > 0.05) (Fig. 2.7A). 
For groups receiving intra-mPFC SKF 38393, analysis of exploratory behaviour 
revealed a significant interaction between group and treatment (F(3,57) = 3.71; p < 
0.01) with post hoc analysis revealing that groups treated with saline (n = 8) or a 
lower dose of SKF 38393 (n = 8; 10 ng/0.5 µl) displayed significant conditioned 
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suppression of exploratory behaviour in response to CS+ versus CS− presentations (p 
< 0.05), whereas this effect was blocked in groups receiving the higher doses of intra-
mPFC SKF 38393 (100 ng/0.5 µl, n = 7; 1000 ng/0.5 µl, n = 8; p > 0.05) (Fig. 2.7B) 
in response to CS+ versus CS− presentations. For groups receiving intra-mPFC SKF 
81297, analysis of exploratory behaviour revealed a significant main effect of 
treatment (F(3,59) = 19.5; p < 0.0001) with post hoc analysis revealing that groups 
treated with saline (n = 6) or the lower doses of SKF 81297 (1 or 10 ng/0.5 µl; n = 8) 
displayed significant conditioned suppression of exploratory behaviour in response to 
CS+ versus CS− presentations (p < 0.05), whereas this effect was blocked in groups 
receiving the higher doses of intra-mPFC SKF 81297 (100 ng/0.5 µl; n = 8) (Fig. 
2.7B) in response to CS+ versus CS− presentations. Thus, in contrast to our 
observations with intra-mPFC DA D4 receptor modulation, pharmacological 
activation of mPFC D1 receptors produced no effect on the encoding of salient or 
nonsalient fear-conditioning stimuli during the acquisition phase of associative 
learning (Fig. 2.6) but dose-dependently blocks the expression (recall) of previously 









Figure 2.7 Behavioural effects of bilateral intra-mPFC DA D1 receptor activation on 
the expression (recall) of suprathreshold associative fear-conditioning memory.  
(A) Rats receiving intra-mPFC saline displayed normal expression (recall) of 
suprathreshold (0.8 mA footshock) fear conditioning when administered saline 
immediately before testing. In contrast, administration of a D1 agonist (SKF 38393; 100–
1000 ng/0.5 µl) immediately before testing completely blocked the expression (recall) of 
previously acquired emotional learning, with rats displaying no significant difference in 
freezing behaviour in response to CS+ relative to CS− presentations. Similarly, bilateral 
intra-mPFC administration of the full D1 receptor agonist SKF 81297 (1–100 ng/0.5 µl) 
produced a dose-dependent attenuation of emotional memory recall at the highest dose of 
100 ng, but not at subthreshold doses (1–10 ng/0.5 µl). (B) Similar effects were observed 
in conditioned suppression of exploratory behaviour scores after CS+ versus CS− 
presentations, with intra-mPFC D1 receptor activation blocking conditioned suppression 
of exploratory behaviour after pretesting microinfusions of SKF 38393 (100–1000 ng/0.5 
µl), relative to saline controls. Bilateral intra-mPFC administration of another D1 receptor 
agonist, SKF 81297 (1–100 ng/0.5 µl), also produced a dose-dependent attenuation of 
emotional memory recall reflected in conditioned suppression of exploratory behaviour, 














Evidence from behavioural, electrophysiological, and neuroanatomical studies 
suggests a complex role for DA transmission within the mPFC during the processing 
of emotional and cognitive information. Studies examining executive processes such 
as set-shifting and cognitive flexibility suggest that optimal levels of D1 or D2-like 
receptor activity are essential for normal cognition and memory function. For 
example, supranormal stimulation of either D1 or D4 receptors within the mPFC 
impairs spatial working memory and/or performance on set-shifting tasks in rodents 
(Zahrt et al., 1997; Floresco et al., 2006). Anomalies in D4 receptor transmission have 
been reported also in schizophrenia (Seeman et al., 1993; Stefanis et al., 1998). 
Nevertheless, little is known about the relative roles of mPFC DA D1 versus D4 
receptor transmission specifically in the context of emotional learning and memory 
processing. 
2.4.1 DA D4 receptors modulate the encoding of salient and 
nonsalient emotional information in the mPFC  
Given the ability of D4 receptor activation to amplify DA-mediated neuronal activity 
within the mPFC (Ceci et al., 1999), we hypothesized that activation of mPFC D4 
receptors may potentiate the emotional salience of normally subthreshold sensory 
stimuli, leading to heightened emotional memory encoding. Our results demonstrate 
that activation of mPFC D4 receptors potentiates the emotional salience of 
subthreshold fear-conditioning stimuli during acquisition but not expression (recall) 
phases of associative learning. However, once associative memories are encoded, D4 
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manipulations no longer appear capable of modulating these memories, consistent 
with findings in single mPFC neurons (Laviolette et al., 2005). Whereas future studies 
are required to examine the precise neuronal basis of this effect, recent in vivo 
electrophysiological evidence demonstrates that D4 receptor agonists can decrease 
feedforward inhibition on mPFC neurons receiving input from the BLA (Floresco and 
Tse, 2007), suggesting the possibility that our observed potentiation of emotional 
associative memory may be attributable to increasing associative information input 
from the BLA to the mPFC, in effect “priming” neurons in the mPFC to receive 
emotionally salient associative information from the BLA. We have reported 
previously that blockade of the D4 receptor within the mPFC can block the encoding 
of emotionally salient olfactory associative learning (Laviolette et al., 2005). This 
may suggest that the encoding of emotionally salient memories requires an optimal 
level of DA D4 receptor stimulation as either overstimulation or blockade of intra-
mPFC D4 receptor transmission can inhibit the encoding of this information.  
 The observed emotional memory potentiating effects of D4 receptor activation 
are intriguing given previous evidence linking D4 receptor activation with 
bidirectional modulation of α-Ca2+/calmodulin-dependent protein kinase II (α-
CaMKII), a molecule involved in synaptic plasticity, learning, and memory (Malenka 
and Nicoll, 1999; Frankland et al., 2001). Gu and Yan (2004) have reported that 
within in vitro slice preparations of rodent mPFC, D4 receptor activation strongly 
increases α-CaMKII activity during low baseline levels of neuronal activity. In 
contrast, during high levels of neuronal activity, D4 agonist application causes a 
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marked decrease in α-CaMKII levels, demonstrating that D4 receptor signaling within 
the mPFC bidirectionally modulates α-CaMKII activity as a function of mPFC 
neuronal activity levels. Thus, one possibility is that our observed potentiation of 
normally nonsalient emotional stimuli (Fig. 2.3) may be related to the ability of D4 
receptor activation to increase endogenous levels of α-CaMKII during periods of low 
mPFC neuronal activity (as may be predicted during exposure to subthreshold 
footshock). Conversely, the ability of mPFC D4 receptor activation to block emotional 
memory formation to suprathreshold, emotionally salient footshock stimuli (Fig. 2.4 
A,B) may be related to D4 receptor-mediated attenuation of endogenous α-CaMKII 
levels, specifically during periods of high neuronal activity within the mPFC (as 
would be predicted after exposure to higher footshock levels) (Gu and Yan, 2004; Gu 
et al., 2006).  
 The present results demonstrate a critical role for prefrontal cortical DA D4 
receptor signaling during the encoding phase of emotional associative memory and 
suggest that perturbations in this system may result in inappropriate associative 
encoding of sensory stimuli via D4 receptor-mediated modulation of emotional 
salience variables. Given that similar psychopathological symptoms are present in 
syndromes such as schizophrenia, autism, and posttraumatic stress disorder, the 
present results may implicate abnormalities in prefrontal cortical DA D4 transmission 
in the emotional processing and memory disturbances observed in such disorders.  
 Previous studies suggest a functional link between the BLA and mPFC both in 
terms of modulating DA-mediated mPFC neuronal network activity and in regulating 
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associative encoding within mPFC neurons (Laviolette et al., 2005, 2006a; Floresco et 
al., 2007). We found that BLA inactivation prevented mPFC D4 agonist-mediated 
potentiation of memory for nonsalient fear stimuli, suggesting that mPFC D4 
modulation of emotional learning depends on functional amygdala input. Although 
the present studies do not differentiate between ascending versus descending 
pathways within the BLA↔mPFC circuit, given that mPFC neurons that respond to 
BLA inputs are involved in emotional memory encoding in mPFC neurons, BLA 
inactivation may prevent the flow of first-order emotional salience information from 
the amygdala to the mPFC, thereby blocking any potentiating effects of D4 receptor 
activation within the mPFC, as suggested by previous studies (Laviolette et al., 2005; 
Laviolette and Grace, 2006a).  
2.4.2 DA D1 receptors modulate the expression (recall), but not the 
encoding, of emotionally salient associative information in 
mPFC  
At the behavioural systems level, systemic or intra-mPFC activation of D1 receptors 
impairs working memory performance (Zahrt et al., 1997) and delayed response 
performance (Cai and Arnsten, 1990; Arnsten et al., 1994). Although few studies have 
examined directly the role of mPFC D1 receptor transmission during the encoding 
and/or recall of emotionally salient associative memories, current theories of mPFC 
DA function have suggested that D1 receptor transmission may be crucial for the 
preservation and recall of memories over temporal delay periods (Durstewitz and 
Seamans, 2008). For example, Seamans et al. (1998) reported that blockade of mPFC 
D1 receptors blocked the ability of rodents to use previously acquired spatial memory 
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during a delayed performance radial arm task, while having no effect on non-delayed 
memory recall. These studies suggest that executive memory functions within mPFC 
neuronal networks may require an optimal level of DA D1 signaling, specifically 
during periods of memory recall, rather than during associative memory encoding. 
Such a role for mPFC D1 signaling is consistent with our findings that whereas D1 
receptor activation had no influence on the acquisition (encoding phase) of emotional 
memory, activation of D1 receptors potently blocked the ability to recall emotional 
associative memory during the expression (test phase) of this learning. Our results 
suggest that D1 receptor-mediated inhibition of mPFC pyramidal neuron activity may 
be a mechanism whereby recall of emotionally salient information can be suppressed 
through DAergic modulation of mPFC neuronal associative memory networks.  
 In terms of DA D1 receptor-mediated control of mPFC neuronal network 
activity, behavioural and electrophysiological evidence implicates DA D1 receptor 
transmission in the modulation of inhibitory, GABAergic interneurons. Specifically, 
activation of mPFC D1 receptors is reported to increase feedforward GABAergic 
inhibition on mPFC pyramidal neurons (Seamans et al., 2001; Seamans and Yang, 
2004). However, because single neurons within the mPFC are capable of actively 
encoding emotional associative learning during the acquisition phase (Laviolette et 
al., 2005; Laviolette and Grace, 2006a), one prediction would be that activation of 
mPFC D1 receptors, which is known to increase feedforward inhibition on mPFC 
pyramidal neurons (Seamans et al., 2001; Gorelova et al., 2002), also would block 
associative memory encoding during the acquisition phase of learning. Instead, we 
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observed no blockade of emotional associative learning acquisition after intra-mPFC 
D1 receptor activation (Fig. 2.6), further demonstrating a functional dissociation in 
mPFC DA D1 function during the acquisition (encoding) versus recall phases of 
emotional learning and memory.  
2.5 CONCLUSION 
 Our results demonstrate distinct functional roles for DA D1 versus D4 receptor 
subtypes during the encoding versus recall phases of emotional associative memory 
within the mPFC and demonstrate a functional role for DA D4 transmission in the 
modulation of the emotional salience value of sensory stimuli during associative 
learning and memory processing. Although the present experiments focused primarily 
on the prelimbic (PLC) division of the mPFC, during the acquisition and expression 
(recall) phases of emotional associative memory, considerable evidence points to a 
functional dissociation between the prelimbic and infralimbic divisions of the mPFC 
during the acquisition versus extinction of emotional memory (Quirk and Mueller, 
2008; Santini et al., 2008), such that neurons within the PLC appear critical for 
emotional memory acquisition whereas infralimbic neurons appear critical for 
extinction-related learning. The present results, although not directly examining the 
role of the infralimbic cortex in DA-related emotional memory acquisition and recall, 




 Future studies are required to examine the potential roles of DA D1 versus D4 
receptor transmission during the extinction phase of emotional memory processing. A 
clearer understanding of the roles of DA D1 versus D4 receptor transmission within 
the mPFC during the processing of emotionally salient associative learning and 
memory may help elucidate how abnormalities in mPFC DA transmission may lead to 
disturbed emotional processing and learning present in disorders such as 
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3.1  INTRODUCTION 
Functional disturbances in frontal cortical DA transmission and CaMKII signaling 
have been implicated in the pathophysiology of neuropsychiatric disorders such as 
schizophrenia and ADHD (Frankland et al. 2008; Lauzon and Laviolette 2010). 
Indeed, DAergic receptor–mediated modulation of the α and β isoforms of CaMKII 
has been shown to be functionally important in the context of animal models of 
psychosis (Greenstein et al. 2007; Yamasaki et al. 2008; Novak and Seeman 2010). 
However, the mechanisms by which DA and CaMKII signaling pathways may 
interact at the systems level to modulate emotional processing are not currently 
understood. The DA D4 receptor subtype is highly expressed in medial prefrontal 
cortex (mPFC) (Ariano et al. 1997; De Almeida and Mengod 2010) and plays a 
crucial modulatory role during the acquisition (encoding) of fear memory (Laviolette 
et al. 2005). Using an olfactory fear conditioning procedure, we have demonstrated 
that activation of D4 receptors within the prelimbic cortex (PLC) division of the 
mPFC potentiates the emotional salience of subthreshold fear conditioning stimuli 
during acquisition but not expression (recall) phases of emotional learning (Lauzon et 
al. 2009). In addition, activation of PLC D4 receptors blocks the acquisition of 
emotionally salient suprathreshold fear memories, demonstrating a fundamental role 
for D4 receptor signaling during the acquisition of emotional memory (Lauzon et al. 
2009; Lauzon and Laviolette 2010).  
 Previous work by Gu et al. (2004, 2006) have shown that activation of cortical 
D4 receptors dynamically and bidirectionally modulate levels of α-CaMKII, a 
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molecule essential for regulating several postsynaptic targets involved in learning and 
memory (Malenka and Nicoll 1999; Frankland et al. 2001; Gu and Yan 2004; Gu et 
al. 2006). Specifically, they reported that D4 receptor activation strongly increases α-
CaMKII activity, resulting from stimulation of phospholipase-C which in turn 
increases intracellular Ca2+ through inositol-1,4,5-triphospate. Interestingly, the D4 
receptor–mediated elevation in α-CaMKII activity was only observed during 
spontaneously low levels of neuronal activity within the mPFC. In contrast, during 
high neuronal activation in the mPFC, activation of D4 receptors led to a decrease in 
α-CaMKII activity, a process mediated via decreased PKA, which in turn increased 
protein phosphotase-1 (PP1) levels, ultimately resulting in dephosphorylation and 
reduced activity of α-CaMKII.  
 We hypothesized that intra-PLC D4 receptor signaling may control the salience 
of emotional memory by coregulating CaMKII levels. Specifically, using an olfactory 
fear conditioning assay in rats, we tested whether intra-PLC D4 receptor activation 
may amplify the emotional salience of normally nonsalient fear stimuli via 
upregulation of CaMKII levels. Furthermore, we examined whether D4 receptor–
mediated blockade of suprathreshold emotional fear memory may depend upon 
indirect modulation of CaMKII signaling via actions on the PP1 and the cAMP/PKA 
signaling pathways. We report that blockade of CaMKII signaling by either direct 
inhibition of CaMKII or blockade of CaMKII autophosphorylation prevents the 
ability of intra-PLC D4 receptor activation to potentiate emotional memory. In 
contrast, activation of cAMP/PKA signaling or inhibition of PP1 rescues D4 receptor–
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mediated blockade of suprathreshold emotional fear memory acquisition, 
demonstrating bidirectional control of fear memory acquisition and salience via 
distinct signaling pathways within the PLC.  
3.2 MATERIALS AND METHODS 
3.2.1 Animals and surgery 
All procedures were performed in accordance with the Canadian Council on Animal 
Care and approved by the University of Western Ontario's Council on Animal Care. 
Male Sprague Dawley rats (300–350 gm; Charles River) were anesthetized with a 
ketamine (80 mg/ml)–xylazine (6 mg/kg) mixture intraperitoneally and placed in a 
stereotaxic device. Stereotaxic coordinates were based upon the atlas of Paxinos and 
Watson (1996). Two stainless steel guide cannulae (22 gauge) were implanted into 
the PLC division of the mPFC using the following stereotaxic coordinates (15° angle; 
in mm from bregma): anteroposterior (AP) +2.9, lateral (LAT) ±1.9, ventral (V) −3.0 
from the dural surface (see Fig. 3.1B). Jeweler's screws and dental acrylic were used 
to secure the cannulae. 
3.2.2 Olfactory fear conditioning  
Procedures for olfactory fear conditioning have been described previously (Chapter 
2). Olfactory fear conditioning took place in 1 of 2 distinct environments, 
counterbalanced within groups: environment A was a 30″ × 30″ Plexiglas box with 
black stripes on a white background, whereas environment B had black dots on a 
white background with a grid shock floor. Testing 24 h later took place in 1 of 2 
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alternate environments, in which animals had not previously received electric shock, 
counterbalanced within groups. On day 1 (habituation phase), animals were 
habituated to a random combination of shock environment A or B and test 
environment A or B in a counterbalanced order for 30 min in each environment. On 
day 2 (conditioning phase), animals were returned to the conditioning room and 
placed in the previously assigned shock environment. During conditioning, one of the 
odours (almond or peppermint) was presented to the animal for 19 s and a footshock 
was delivered (0.4 mA or 0.8 mA) for 1 s. These 2 different levels of footshock (0.4 
mA and 0.8 mA) correspond to subthreshold and suprathreshold levels of fear 
conditioning stimuli, as reported previously (Laviolette and Grace 2006). One 
hundred and twenty seconds later, the alternate odour was presented for 20 s (CS−) in 
the absence of footshock. This cycle was repeated 5 times. On the following day (test 
phase), rats were returned to the test room and placed in the previously assigned test 
environment. Before odour presentation, the rat was allowed to explore the 
environment for 1 min and baseline levels of freezing and exploratory behaviour were 
observed. Odours (CS+ or CS−) were presented for 5 min each to the animal in a 
counterbalanced order, and the amount of time freezing was recorded. Freezing 
behaviour was defined as complete immobility with the exception of respiratory-
related movement. We also analyzed exploratory behaviour in response to 
presentations of CS+ or CS− odours, as described previously (Lauzon et al. 2009). 
Exploratory behaviour was scored as follows, with a score assigned for every min of 
each of the 5 min during the CS+ or CS− odour presentations: 0, no locomotion; 1, 
ambulation across 1 side of the testing chamber; 2, ambulation across 2 sides; 3, 
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exploration of the full perimeter of the testing chamber; and 4, exploration of the 
center and entire perimeter of the test chamber. Experimental procedures and timeline 
for examining olfactory fear memory acquisition are summarized schematically in 
Figure 3.1A. 
3.2.3 Drug administration 
All drugs were dissolved in physiological saline, with pH adjusted to 7.4. Bilateral 
intra-mPFC microinjection of either saline vehicle, the selective D4 agonist PD 
168077 (Tocris) (50 ng/0.5 µL), the selective CaMKII inhibitors; Autocamtide-2-
related inhibitory peptide, AIP (Tocris, 5–50 ng/0.5 µL) and KN-62 (Tocris, 2.5–250 
ng/0.5 µL), the cAMP analog and protein kinase activator 8-CPT-cAMP (BioMol, 
50–500 ng/0.5 µL), or the selective PP1 inhibitor tautomycetin (Tocris, 10–200 ng/0.5 
µL) were microinfused immediately prior to the olfactory conditioning procedure. 
3.2.4 Histology 
Following experimental completion rats were perfused, brains were removed, and 
stored in a formalin/25% sucrose solution for 24 h. Brains were sectioned into 40 µm 
coronal slices, mounted, and stained using cresyl violet to allow for histological 
analysis of the site of injection. The majority of mPFC placements were localized 
within the boundaries of the prelimbic cortical area (PLC). Rats found to have 
misplaced guide cannulae were excluded from behavioural analysis. 
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3.2.5 Data analysis 
Data were analyzed with one-, two-, or three-way analysis of variance (ANOVA) 
where appropriate or Student's t-tests. Post hoc analyses were performed with Fisher’s 
least significant difference and Newman–Keuls tests. 
3.3 RESULTS 
3.3.1 Histological analysis 
Histological analysis revealed microinfusion injector cannulae placements to be 
bilaterally localized within the anatomical boundaries of PLC region of the mPFC, as 
determined by the atlas of Paxinos and Watson (1996). In Figure 3.1B, we present a 
microphotograph showing a typical representative injector placement within the PLC. 
In Figure 3.1C, we present a schematic illustration showing representative intra-PLC 
bilateral cannulae placements along the rostrocaudal axis of the PLC.  
3.3.2 Intra-PLC inhibition of CaMKII blocks DA D4-mediated 
potentiation of subthreshold fear stimuli 
We first examined the effects CaMKII inhibition on D4-mediated potentiation of 
subthreshold fear stimuli by simultaneously activating DA D4 receptors and inhibiting 
CaMKII in the mPFC during the subthreshold (0.4 mA) fear conditioning procedure. We 
performed bilateral intra-mPFC microinfusions of either saline, a specific DA D4 agonist; 
PD 168077 (50 ng/0.5 µL) alone, and coadministered the selective CaMKII inhibitor; 
KN-62 (2.5, 25, or 250 ng/0.5 µL) or AIP (5 or 50 ng/0.5 µL) immediately prior to fear 
conditioning training. KN-62 inhibits CaMKII activity by binding directly to the 








Figure 3.1 Histological analysis of intra-mPFC microinjection sites and 
experimental protocol summary.    
(A) Microphotograph of a representative injector placement within the mPFC (white 
arrow represents injector tip location). (B) Schematic representation showing 
experimental associative fear conditioning assay and timeline for examining the 
acquisition (encoding) of associative olfactory fear memory. (C) Schematic illustration 
showing representative bilateral placements of microinjection cannulae. For illustrative 
clarity, only a subset of experimental groups is presented. Symbols represent separate 
experimental groups; ,  D4 agonist PD168077; 50ng/0.5µl vs. acquisition of sub-
threshold emotional stimuli; , D4 agonist PD168077 50ng/0.5µl vs. acquisition of 
supra-threshold emotional stimuli; ,  Saline vs. acquisition of sub-threshold emotional 









 In contrast, AIP decreases CaMKII activity by binding to the 
autophosphorylation site, independently of Ca2+/calmodulin activity (Ishida et al. 
1995; Yang et al. 2004). Examining the behavioural effects of coadministration with 
KN-62, ANOVA revealed a significant interaction between group and treatment 
(F(5,89) = 7.43, p < 0.0001) on times spent freezing to either CS+ or CS− cue 
presentations at testing. Post hoc analysis illustrated a potentiation in associative fear 
conditioning expression by both PD 168077 50 ng/0.5 µL alone (n = 7, p < 0.01) and 
when coadministered with the lowest dose of KN-62, 2.5 ng/0.5 µL (n = 8, p < 0.01) 
demonstrated by a significantly greater time spent freezing to the CS+ compared with 
the CS− (Fig. 3.2A). In contrast, post hoc analysis revealed no significant difference 
between freezing time to the CS+ compared with the CS− for the saline (n = 8, p > 
0.05) control group or animals receiving coadministration of PD 168077 with the 
higher doses of KN-62, 25 ng/0.5 µL (n = 8; p > 0.05), and 250 ng/0.5 µL (n = 8, p > 
0.05) (Fig. 3.2A). To determine if intra-mPFC KN 62 produced any 
learning/inhibition on acquisition of fear memory, we included a control experiment 
wherein rats received the highest effective dose of KN-62 (250 ng/0.5 µL) alone 
during suprathreshold fear conditioning. Post hoc analysis revealed that KN-62, 250 
ng/0.5 µL (n = 8, p < 0.01) alone did not influence the acquisition of suprathreshold 
fear memory, demonstrated by a significantly greater time spent freezing to the CS+ 
compared with the CS− (Fig. 3.2A, right side). Similarly, ANOVA of spontaneous 
exploratory behaviour during presentations of either CS+ or CS− revealed a 
significant interaction between group and treatment (F(5,89) = 4.98, p = 0.001). Post 
hoc analysis revealed rats treated with either PD 168077 50 ng/0.5 µL alone (n = 7, p 
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< 0.01) or PD 168077 50 ng/0.5 µL coadministered with the lowest dose of KN-62, 
2.5 ng/0.5 µL (n = 8; p < 0.01) displayed significantly decreased exploratory 
behaviour in response to the CS+ relative to the CS− (Fig. 3.2B). In contrast, post hoc 
analysis revealed no significant difference in exploratory behaviour observed in 
response to the CS+ compared with the CS− for the saline (n = 8, p > 0.05) control 
group or animals receiving coadministration of PD 168077 (50 ng/0.5 µL) with the 
higher doses of KN-62, 25 ng/0.5 µL (n = 8, p > 0.05), and 250 ng/0.5 µL (n = 8, p > 
0.05) (Fig. 3.2B). To further investigate the effect of CaMKII inhibition on 
acquisition of associative learning, we included a control experiment (n = 8) wherein 
rats received the highest dose of KN-62 (250 ng/0.5 µL) alone during the 
subthreshold fear conditioning procedure. Post hoc analysis revealed that KN-62 (250 
ng/0.5 µL, n = 8, p < 0.01) alone produced a potentiation in associative learning 
demonstrated by significantly decreased exploratory behaviour in response to the CS+ 
relative to the CS− (Fig. 3.2B, right side). 
3.3.3 Blockade of intra-mPFC CaMKII autophosphorylation blocks 
D4 receptor–mediated emotional memory potentiation 
Next, we examined the possible effects of simultaneously activating DA D4 receptors 
and inhibiting CaMKII in the mPFC during the subthreshold (0.4 mA) fear 
conditioning procedure. We performed bilateral intra-mPFC microinfusions of either 
saline, a specific DA D4 agonist; PD 168077 (50 ng/0.5 µL) alone, or coadministered 
with specific CaMKII inhibitor; AIP (5 or 50 ng/0.5 µL) immediately prior to fear 
conditioning, to determine the effects of CaMKII inhibition on D4 receptor–mediated 
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potentiation of emotional learning during the acquisition phase (encoding) of this 
associative information. ANOVA revealed a significant interaction between group 
and treatment (F(3,51) = 8.11, p = < 0.01) on time spent freezing to either CS+ or CS− 
cue presentations at testing. Post hoc analysis illustrated a potentiation in associative 
fear conditioning expression by both PD 168077 50 ng/0.5 µL alone (n = 7, p < 0.01) 
and when coadministered with the lowest dose of AIP, 5 ng/0.5 µL (n = 8, p < 0.01) 
demonstrated by a significantly greater time spent freezing to the CS+ compared with 
the CS− (Fig. 3.3A). In contrast, post hoc analysis revealed no significant difference 
between freezing time to the CS+ compared to the CS− for the saline (n = 8, p > 0.05) 
control group or animals receiving coadministration of PD 168077 with the highest 
dose of AIP, 50 ng/0.5 µL (n = 8, p > 0.05) (Fig. 3.3A). 
 ANOVA of exploratory behaviour scores during CS+/CS− presentations revealed 
a significant interaction between group and treatment (F(3,51) = 5.16, p ≤ 0.01). Post hoc 
analysis revealed rats treated with either PD 168077 50 ng/0.5 µL alone (n = 7, p < 0.01) 
or PD 168077 50 ng/0.5 µL coadministered with the lowest dose of AIP, 5 ng/0.5 µL (n = 
8; p < 0.01) displayed significantly decreased exploratory behaviour in response to the 
CS+ relative to the CS− (Fig. 3.3B). In contrast, post hoc analysis revealed there was no 
significant difference in exploratory behaviour observed in response to the CS+ 
compared to the CS− for the saline (n = 8, p > 0.05) control group or animals receiving 
coadministration of PD 168077 5 ng/0.5 µL with the highest dose of AIP, 50 ng/0.5 µL (n 







Figure 3.2 Effects of intra-mPFC DA D4 receptor and CaMKII inhibition during 
fear-conditioning.  
(A) Saline controls displayed no significant difference in time spent freezing in response 
to CS+ vs. CS− presentations following subthreshold (0.4 mA; see Materials and 
Methods) fear conditioning. In contrast, intra-PLC PD 168077 (50 ng/0.5 µL) 
significantly potentiated the acquisition of subthreshold fear memory. Coadministration 
with the CaMKII inhibitor KN-62 (2.5–250 ng/0.5 µL dose dependently attenuates the 
effects of D4 receptor activation. In contrast, intra-PLC KN-62 (250 ng/0.5 µL) alone did 
not have a significant effect on the acquisition of suprathreshold (0.8 mA) fear memory. 
(B) Analysis of exploratory scores revealed that saline controls showed no CS+-related 
exploratory behaviour suppression. In contrast, PD 168077 (50 ng/0.5 µL) significantly 
potentiated CS+-related suppression of exploratory behaviour, which was dose 
dependently blocked by coadministration of KN-62 (2.5–250 ng/0.5 µL). Bars represent 















Figure 3.3 Effects of intra-PLC D4 receptor activation and blockade of CaMKII 
autophosphorylation on fear-conditioning.  
(A) Saline controls showed no significant CS+-related freezing behaviour. In contrast, 
PD 168077 (50 ng/0.5 µL) significantly potentiated the acquisition of subthreshold 
olfactory fear memory, demonstrated by significantly greater CS+ freezing behaviour. 
This effect was dose dependently blocked by coadministration of the CaMKII 
autophosphorylation inhibitor AIP (5–50 ng/0.5 µL). (B) Analysis of fear memory-related 
exploratory scores revealed that saline control rats showed no associative suppression of 
spontaneous exploratory behaviour. In contrast, PD 168077 (50 ng/0.5 µL) significantly 
potentiated the acquisition of subthreshold (0.4 mA footshock) fear memory, 
demonstrated by significant suppression of CS+-related exploratory scores. This effect 















3.3.4 Intra-mPFC inhibition of PP1 rescues DA D4-mediated 
blockade of emotionally salient fear stimuli 
We next examined the possible effects of simultaneously activating DA D4 receptors 
and inhibiting PP1 in the mPFC during suprathreshold (0.8 mA) fear conditioning. 
We performed bilateral intra-mPFC microinfusions of either saline, a specific DA D4 
agonist; PD 168077 (50 ng/0.5 µL) alone, or coadministered with a specific PP1 
inhibitor; tautomycetin (10, 100, or 200 ng/0.5 µL) immediately prior to fear 
conditioning, to determine the effects of PP1 inhibition on D4 receptor–mediated 
block of suprathreshold fear memory acquisition. ANOVA revealed a significant 
main effect of treatment (F(4,68) = 6.80, p < 0.0001) on time spent freezing to either 
CS+ or CS− cue presentations at testing. Post hoc analysis illustrated an attenuation 
of associative fear conditioning acquisition by both PD 168077 50 ng/0.5 µL alone (n 
= 7, p > 0.05) and when coadministered with the lower doses of tautomycetin, 10 
ng/0.5 µL (n = 8, p > 0.05) and 100 ng/0.5 µL (n = 8, p > 0.05) demonstrated by no 
significant difference in the time spent freezing to the CS+ compared to the CS− (Fig. 
3.4A). In contrast, post hoc analysis revealed a significant difference between 
freezing time to the CS+ compared to the CS− for the saline (n = 7, p < 0.05) control 
group and animals receiving coadministration of PD 168077 50 ng/0.5 µL with the 
highest dose of tautomycetin, 200 ng/0.5 µL (n = 8, p < 0.05) (Fig. 3.4A).  
 To further investigate the effect of PP1 inhibition on acquisition of associative 
learning, we included a control experiment (n = 7) wherein rats received the highest 
dose of tautomycetin (200 ng/0.5 µL) alone during suprathreshold fear conditioning. 
Post hoc analysis revealed that tautomycetin 200 ng/0.5 µL (t(6) = 2.18, p < 0.05) 
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alone did not block suprathreshold acquisition in associative learning demonstrated by 
a significantly greater time spent freezing to the CS+ compared to the CS− (Fig. 3.4A, 
right side). ANOVA of exploratory behaviour scores during CS+/CS− presentations 
revealed a significant main effect of treatment (F(4,68) = 6.27, p  < 0.001). Post hoc 
analysis revealed rats treated with either PD 168077 50 ng/0.5 µL alone (n = 7, p > 
0.05) or PD 168077 50 ng/0.5 µL coadministered with the lower doses of 
tautomycetin, 10 ng/0.5 µL (n = 8, p  > 0.05) and tautomycetin 100 ng/0.5 µL (n = 8, 
p > 0.05) displayed no significant difference exploratory behaviour in response to the 
CS+ relative to the CS− (Fig. 3.4B). In contrast, post hoc analysis revealed a 
significant difference in exploratory behaviour in response to the CS+ compared to 
the CS− for the saline (n = 8, p < 0.05) control group and animals receiving 
coadministration of PD 168077 50 ng/0.5 µL with the highest dose of tautomycetin, 
200 ng/0.5 µL (n = 8, p < 0.05) (Fig. 3.4B). To further investigate the effect of PP1 
inhibition on acquisition of associative learning, we included a control experiment (n 
= 7) wherein rats received the highest dose of tautomycetin (200 ng/0.5 µL) alone 
during the suprathreshold fear conditioning procedure. Statistical analysis revealed 
that tautomycetin (200 ng/0.5 µL) (t(6) = 2.29, p < 0.05) alone did not block 
suprathreshold acquisition in associative learning demonstrated by a significantly 









Figure 3.4 Inhibition of PP1 rescues DA D4 receptor–mediated blockade of 
suprathreshold fear memory acquisition.  
(A) Saline controls showed significant freezing to CS+ presentations after conditioning 
with a suprathreshold footshock (0.8 mA). In contrast, intra-PLC PD 168077 (50 ng/0.5 
µL) blocked the acquisition of suprathreshold fear memory. This effect was dose 
dependently reversed by coadministration of tautomycetin (10–200 ng/0.5 µL). In a 
separate control experiment, intra-PLC tautomycetin (200 ng/0.5 µL) alone did not 
influence the acquisition of suprathreshold fear memory. (B) Saline controls showed 
significant suppression of exploratory behaviour in response to CS+ presentations. In 
contrast, intra-PLC PD 168077 (50 ng/0.5 µL) blocked this effect. D4-mediated blockade 
of suprathreshold fear memory acquisition was dose dependently reversed by 
tautomycetin (10–200 ng/0.5 µL). In a separate control experiment, intra-PLC 


















3.3.5 Activation of protein kinase A rescues DA D4-mediated 
blockade of suprathreshold fear memory acquisition 
We next performed bilateral intra-PLC microinfusions of either saline, PD 168077 
(50 ng/0.5 µL) alone, coadministration with the PKA activator; 8-CPT-cAMP (50 ng 
or 500 ng/0.5 µL), or 8-CPT-cAMP alone (control, 500 ng/0.5 µL) to examine the 
effects of intra-PLC PKA activation on D4 receptor–mediated block of suprathreshold 
fear memory acquisition. ANOVA revealed a significant effect of treatment (F(3,61) = 
9.23, p < 0.0001) on time spent freezing to either CS+ or CS− cue presentations at 
testing. Post hoc analysis illustrated an attenuation of associative fear conditioning 
acquisition by both PD 168077 50 ng/0.5 µL alone (n = 7, p  > 0.05) and when 
coadministered with the lowest dose of 8-CPT-cAMP, 50 ng/0.5 µL (n = 8, p > 0.05) 
demonstrated by no significant difference in the time spent freezing to the CS+ 
compared to the CS− (Fig. 5A). In contrast, post hoc analysis revealed a significant 
difference between freezing time to the CS+ compared to the CS− for the saline (n = 
7, p < 0.05) control group and animals receiving coadministration of PD 168077 50 
ng/0.5 µL with the highest dose of 8-CPT-cAMP, 500 ng/0.5 µL (n = 8, p < 0.05) 
(Fig. 3.5A). To further investigate the effect of PKA activation on acquisition of 
associative learning, we included a control experiment (n = 8) wherein rats received 
the highest dose of 8-CPT-cAMP, (500 ng/0.5 µL) alone during suprathreshold fear 
conditioning. Statistical analysis revealed that 8-CPT-cAMP 500 ng/0.5 µL (t(7) = 
3.34, p ≤ 0.05) alone did not block suprathreshold fear memory acquisition 
demonstrated by significantly greater times spent freezing to the CS+ relative to the 








Figure 3.5 Activation of cAMP/PKA signaling rescues D4 receptor–mediated 
blockade of suprathreshold fear memory.  
(A) Saline controls showed significant CS+-related freezing after conditioning with 
suprathreshold footshock (0.8 mA). However, intra-PLC PD 168077 (50 ng/0.5 µL) 
blocked acquisition of suprathreshold fear memory. This effect was dose dependently 
reversed by coadministration of the cAMP/PKA activator 8-CPT-cAMP (50–500 ng/0.5 
µL). In a separate control experiment, intra-PLC 8-CPT-cAMP (500 ng/0.5 µL) alone did 
not influence the acquisition of suprathreshold fear memory. (B) Similarly, exploratory 
behaviour analyses demonstrated significant CS+-related attenuation in exploratory 
behaviour in saline controls. In contrast, intra-PLC PD 168077 (50 ng/0.5 µL) 
administration blocked this effect. D4 receptor–mediated blockade of suprathreshold fear 
memory acquisition was dose dependently reversed by coadministration of 8-CPT-cAMP 
(50–500 ng/0.5 µL). Intra-PLC 8-CPT-cAMP (500 ng/0.5 µL) alone did not have any 















 ANOVA of spontaneous exploratory behaviour during presentations of either 
CS+ or CS− revealed a significant effect of treatment (F(3,61) = 11.18, p < 0.0001). 
Post hoc analysis revealed rats treated with either PD 168077 50 ng/0.5 µL alone (n = 
7; p > 0.05) or PD 168077 50 ng/0.5 µL coadministered with the lowest dose of 8-
CPT-cAMP 50 ng/0.5 µL (n = 8, p > 0.05) displayed no significant difference 
exploratory behaviour in response to the CS+ relative to the CS− (Fig. 3.5B). In 
contrast, post hoc analysis revealed there was a significant difference in exploratory 
behaviour observed in response to the CS+ compared to the CS− for the saline (n = 8, 
p < 0.05) control group and animals receiving coadministration of PD 168077 50 ng 
with the highest dose of 8-CPT-cAMP 500 ng/0.5 µL (n = 8, p  < 0.01) (Fig. 5B). To 
investigate the effect of PKA activation on acquisition of associative learning, we 
included a control experiment (n = 8) wherein rats received the highest dose of 8-
CPT-cAMP (500 ng/0.5 µL) alone during the suprathreshold fear conditioning 
procedure. Post hoc analysis revealed that 8-CPT-cAMP 500 ng (t(7) = 2.30, p < 
0.037) alone did not block suprathreshold acquisition in associative learning 
demonstrated by a significantly decreased exploratory behaviour in response to the 
CS+ relative to the CS− (Fig. 3.5B, right side). 
3.4 DISCUSSION 
DA D4 receptor transmission within the mPFC is an important modulator of 
emotional memory acquisition, in single neurons and at the behavioural level. 
Blockade of DA D4 receptor transmission, either systemically or directly within the 
PLC division of the mPFC prevents the acquisition, but not the expression, of 
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associative fear memory (Laviolette et al. 2005; Lauzon et al. 2009). In addition, 
pharmacological activation of DA D4 receptors in the PLC dose dependently 
potentiates the emotional salience of normally nonsalient subthreshold fear 
conditioning stimuli (footshock) and blocks the acquisition of emotionally salient 
(suprathreshold) associative fear memories (Lauzon et al. 2009). Thus, DA D4 
receptor transmission within the mPFC can bidirectionally modulate fear memory 
acquisition by regulating the emotional salience of these memories; potentiating 
nonsalient emotional memory while blunting the acquisition of highly salient 
emotional memories. However, the downstream molecular events involved in D4-
mediated modulation of emotional memory salience have not previously been 
identified.  
Within the mPFC, CaMKII signaling is bidirectionally modulated by D4 receptor-
specific activation (Gu and Yan 2004; Gu et al. 2006). Using in vitro culture 
preparations of mPFC neurons, Gu and Yan (2004) demonstrated that during low 
levels of mPFC neuronal activity, D4 receptor activation strongly increased α-CaMKII 
activity. In contrast, during high levels of neuronal activation, D4 receptor activation 
strongly attenuated α-CaMKII activity. Taken together, these studies provide a 
functional molecular framework whereby D4 receptor activation may modulate 
memory-related CaMKII signaling within the PFC, depending upon baseline levels of 
neuronal activity within mPFC networks. Given previous evidence that emotionally 
salient events can strongly activate prefrontal cortical networks (Surguladze et al. 
2011; Dickie et al. 2011; Dresler et al. 2011), we hypothesized that the D4-mediated 
  
119
bidirectional modulation of α-CaMKII may be related to the ability of D4 receptor 
activation to modulate the behavioural acquisition of emotional associative memories, 
depending upon the baseline emotional salience (sub vs. suprathreshold footshock 
levels) of the fear conditioning stimulus. Specifically, we proposed that the observed 
potentiation of normally subthreshold emotional stimuli may be related to the ability 
of D4 receptor activation to increase endogenous levels of CaMKII during low levels 
of neuronal activity (corresponding to exposure to subthreshold nonsalient footshock 
stimuli). Such an increase in mPFC CaMKII levels was predicted to potentiate the 
strength of associative fear memory.  
3.4.1 CaMKII bidirectionally regulates fear memory salience via 
DA D4 transmission in the mPFC 
Our results demonstrate that intra-PLC inhibition of CaMKII signaling, dose 
dependently blocked the ability of D4 receptor activation to potentiate normally 
subthreshold olfactory fear memories. This effect was observed with both a direct 
inhibitor of CaMKII signaling via KN-62, which blocks the calmodulin-binding site; 
or with AIP, which blocks autophosphorylation of CaMKII, independently of 
Ca2+/calmodulin activity. Given the ability of D4 receptor activation to increase 
CaMKII during low neuronal activation these results suggest that CaMKII activity 
downstream of the D4 receptors is a probable molecular mechanism underlying D4-
mediated potentiation of subthreshold fear stimuli. It is important to note that neither 
of the CaMKII inhibitors used in the present study are specific enough to differentiate 
between the β and the α isoforms of CaMKII, and future studies will be required to 
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more precisely characterize the precise CaMKII substrate linked to D4 receptor–
mediated modulation of emotional memory, in vivo. Interestingly, administration of 
CaMKII inhibitors alone failed to modulate fear memory acquisition, suggesting that 
intra-mPFC blockade of CaMKII in and of itself is not sufficient to prevent the 
acquisition of fear memory or produce nonspecific impairments in learning or 
memory. Rather, consistent with in vitro evidence, intra-mPFC CaMKII signaling 
appears to depend upon co-activation of D4 receptor substrates for the modulation of 
emotional memory salience.  
 To investigate the bidirectional nature of the relationship between D4 receptor 
activation and α-CaMKII, we administered a PKA activator during D4-mediated block 
of acquisition of emotionally salient fear stimuli. During high levels of mPFC 
neuronal activity, D4 activation initiates an inhibitory downstream cascade resulting 
in increased PKA activity, which in turn increases PP1-mediated dephosphorylation 
of α-CaMKII (Gu and Yan 2004). We hypothesized that this inhibition of CaMKII 
activity may be responsible for our observed blockade of suprathreshold fear memory 
acquisition. Currently, there is no direct or specific pharmacological method to 
activate CaMKII in vivo. Thus, we targeted indirect components of D4 receptor–
mediated control of CaMKII in vivo by either pharmacologically increasing PKA 
activity or inhibiting PP1 activity. As predicted by previous in vitro studies, our 
behavioural results demonstrate that pharmacological activation of PKA or inhibition 
of PP1 can dose dependently rescue D4-mediated blockade of suprathreshold fear 
memory acquisition. Taken together with the KN-62 and AIP findings, regulation of 
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CaMKII activity provides strong evidence of a specific molecular mechanism through 
which the D4 receptors exert their bidirectional effect during the acquisition phase of 
emotional learning.  
 Functionally, D4 receptor–mediated modulation of α-CaMKII within the PLC 
may elucidate a molecular mechanism underlying abnormalities in emotional 
processing, learning, and memory observed in neuropsychiatric disorders such as 
schizophrenia, PTSD, ADHD, and addiction (Lauzon and Laviolette 2010). Various 
lines of evidence suggest that an optimal level of D4 receptor signaling within the 
mPFC is required for adaptive emotional learning, memory, and the development of 
appropriate adaptive behavioural and psychological responses. Specifically, whereas 
hyperstimulation of D4 receptor transmission within the PLC may abnormally amplify 
the emotional salience of subthreshold sensory experiences; hyperstimulation of these 
same D4 receptor substrates in the context of emotionally salient experiences may 
pathologically blunt the emotional salience of these memories leading to suboptimal 
emotional processing and memory encoding, as previously suggested (Lauzon et al. 
2009; Lauzon and Laviolette 2010). Our findings demonstrate that D4 receptor 
transmission exerts bidirectional modulation of emotional memory salience through 
interactions with CaMKII signaling pathways.  
 A functional role for intra-PLC CaMKII signaling during emotional memory 
formation is consistent with previous evidence implicating CaMKII as a critical 
mediator of associative memory formation in PFC networks (Frankland et al. 2001). 
Indeed, CaMKII is highly expressed in the mammalian forebrain and plays a critical 
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role in modulating various postsynaptic elements important for synaptic plasticity, 
learning, and memory (Malenka and Nicoll 1999; Frankland et al. 2001). 
Interestingly, the genetic locus of CaMKII is found on 5q32, a genomic region that 
has been associated with schizophrenia in several clinical studies (Paunio et al. 2001; 
Sklar et al. 2004). In addition, postmortem studies have revealed that CaMKII-β and 
α−isoforms are abnormally expressed in prefrontal cortical areas in individuals with 
schizophrenia and linked to schizophrenia-related behavioural abnormalities in rodent 
models (Novak et al. 2006; Novak and Seeman 2010; Seeman et al. 1993). The 
present findings thus add to a growing body of evidence linking CaMKII signaling to 
the aberrant emotional regulation present in schizophrenia-related psychoses, 
providing a potential DA receptor-specific substrate through which CaMKII signaling 
may control emotional salience processing and memory formation.  
 Recent in vitro work by Yuen and Yan (2011) has demonstrated that D4 
receptor–mediated modulation of CaMKII activity is tightly linked to AMPA receptor 
synaptic activity within the mPFC. Thus, during low mPFC neuronal activity levels, 
D4-mediated activation of CaMKII results in a potentiation in AMPA receptor 
synaptic efficacy whereas during high neuronal activity levels, D4 receptor activity 
decreases CaMKII levels concomitant with decreased AMPA receptor signaling. 
Given the essential role of AMPA-mediated glutamatergic signaling in learning and 
memory-related synaptic plasticity, this may provide another potential mechanism by 
which D4 signaling within the PLC may control emotional memory formation and 
processing via CaMKII modulation. The present results demonstrate an important role 
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for D4 receptor–mediated modulation of CaMKII, cAMP/PKA, and PP1 directly 
within the mPFC, controlling the salience of emotional memory acquisition. 
Interestingly, previous evidence from clinical trials has largely demonstrated a lack of 
therapeutic efficacy for D4 receptor specific antagonists in the treatment of 
schizophrenia-related psychopathology (Kramer et al. 1997; Corrigan et al. 2004). 
Nevertheless, the highly effective atypical antipsychotic, clozapine, demonstrates 
high affinity for the D4 receptor subtype relative to other D2-like receptors 
(Govindaiah et al. 2010). The present results suggest that modulation of downstream 
molecular targets of intra-PLC D4 receptor substrates, such as CaMKII, may serve as 
potential pharmacotherapeutic targets in the context of aberrant D4 receptor signaling 
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4 Supra-normal Stimulation of Dopamine D1 Receptors in 
the Prelimbic Cortex Blocks Spontaneous Recall of both 
Aversive and Rewarding Associative Memories 
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spontaneous recall of both aversive and rewarding associative memories through a cyclic-AMP dependent 




The processing of associative memories related to either rewarding or aversive 
experiences is critically dependent upon DA transmission within the mPFC (Bishop et 
al., 2010; Sun et al., 2011; Lauzon and Laviolette, 2010; Laviolette and Grace, 2006; 
Pezze et al., 2003). Disturbances in DAergic transmission within these cortical 
memory networks substrates may potentially lead to maladaptive emotional memory 
formation and/or recall, characteristic of various neuropsychiatric conditions, such as 
schizophrenia, addiction or PTSD (Lauzon and Laviolette, 2010; Laviolette and 
Grace, 2006). Indeed, PTSD and addiction are characterized by recurrent and 
persistent activation of memories linked to emotionally salient experiences, either 
traumatically aversive or drug-related rewarding experiences. In either case, an 
inability to suppress spontaneous memory recall related to these experiences may be 
an underlying neuropsychological feature triggering anxiety in the case of PTSD, or 
relapse-related behaviours in the context of addiction.  
 A considerable amount of research has demonstrated that receptor-specific 
DAergic transmission within the mPFC may strongly modulate emotional memory 
formation at both the level of the single neuron and the behavioural systems levels 
(Laviolette et al., 2005; Lauzon et al., 2009). We have previously reported dissociable 
functional roles for DA D2 vs. D1-like receptor transmission within the prelimbic 
(PLC) division of the mPFC, in the context of fear memory acquisition and recall. 
Thus, direct activation of the DA D4 receptor subtype strongly potentiates the 
emotional salience of normally non-salient fear conditioning cues during the 
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acquisition (but not recall) memory phase of an olfactory fear memory (Lauzon et al., 
2009; 2011). In contrast, intra-PLC D1 receptor activation has no role in modulating 
emotional salience during memory acquisition, but dose-dependently blocks the acute 
recall of previously learned fear memories (Lauzon et al, 2009) suggesting a specific 
role for intra-PLC D1 receptor transmission during memory recall. These results are 
consistent with reports demonstrating that supranormal stimulation of D1 receptor-
specific substrates in the PFC impairs memory performance in both rodents and non-
human primates (Zahrt et al., 1997; Arnsten et al., 1994). 
  Neuronal populations within the mPFC have been shown to encode 
associative memories related to either rewarding or aversive conditioning events. For 
example, single neurons in the mPFC demonstrate associative firing activity during 
the acquisition and recall of memories related to the rewarding effects of opiates (Sun 
et al., 2010; 2012) or the aversive stimulus properties of fear-related cues (Laviolette 
et al., 2005; Laviolette and Grace, 2006). However, the mechanisms by which DA 
receptor activation within the PLC may modulate the recall of emotionally salient 
associative memories are not currently understood. The goal of the present study was 
to further elucidate the functional effects of intra-PLC D1 receptor modulation on 
memory recall by examining the temporal characteristics of D1-receptor mediated 
block of both aversive and rewarding associative memory recall, and the downstream 
molecular substrates linked to these behavioural effects. Accordingly, we conducted a 
series of behavioural pharmacological studies examining the role of intra-PLC D1 
receptor transmission during the expression (recall) phase of emotional learning and 
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memory processing, employing both an olfactory fear conditioning procedure and a 
morphine reward conditioned place preference (CPP) procedure. We report that 
supranormal stimulation of intra-PLC D1, but not D2 receptor transmission, induces a 
transient block of associative memory recall for both rewarding and aversive 
conditioning events, through a common cAMP-dependent molecular signaling 
substrate. 
4.2 MATERIALS AND METHODS 
4.2.1 Animals and surgery 
Male Sprague Dawley rats (300-350 gm) were obtained from Charles River 
Laboratories. All procedures were performed in accordance with the Canadian 
Council on Animal Care and were approved by the University of Western Ontario’s 
Council on Animal Care. Rats were anesthetized with a ketamine (80 mg/ ml)-
xylazine (6 mg/ kg) mixture administered intraperitoneally (i.p.), and placed in a 
stereotaxic device. All stereotaxic coordinates were based upon the atlas of Paxinos 
and Watson (1996). Two stainless steel guide cannulae (22 gauge) were implanted 
into the PLC using the following stereotaxic coordinates (15º angle; in mm from 
bregma): anteroposterior (AP) +2.9, lateral (LAT) ±1.9, ventral V -3.0 from the dural 
surface, Jeweler’s screws and dental acrylic were used to secure the cannulae.  
4.2.2 Olfactory fear conditioning  
Procedures for olfactory fear conditioning have been described previously (Lauzon et 
al., 2009; 2011) Rats were taken from their home cages, received sham 
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microinfusions into the PLC, and habituated for 30 min in a ventilated conditioning 
chamber with an electric grid floor inside a sound-attenuated room. Olfactory fear 
conditioning took place in one of two distinct environments, counterbalanced within 
groups: “shock” environment A was a 30” x 30” Plexiglas box with black stripes on a 
white background and a metallic grid shock floor, whereas shock environment B was 
a 30” x 30” Plexiglas box with black dots on a white background with a grid shock 
floor. Testing 24 h later took place in one of two alternate environments, in which 
animals had not previously received electric shock, counterbalanced within groups: 
test environment A had walls with black dots and a grey Plexiglas floor, whereas test 
environment B had walls with black and white stripes and a grey Plexiglas floor. On 
day 1 (habituation phase), animals were habituated to a random combination of shock 
environment A or B and test environment A or B in a counterbalanced order for 30 
min in each environment. On day 2 (conditioning phase), animals were returned to the 
conditioning room and placed in the previously assigned shock environment. During 
the conditioning phase, one of the odours (almond or peppermint) was presented to 
the animal for 19 s, and a footshock was then delivered (0.8mA) for 1 s. This level of 
footshock (0.8mA) produces robust conditioned fear memories, as reported 
previously (Laviolette and Grace, 2006a). 120 s later, the alternate odour was 
presented for 20 s (CS-) in the absence of footshock. This cycle was repeated five 
times. On the following day (test phase), rats were returned to the test room and 
placed in the previously assigned test environment. Before odour presentation, the rat 
was allowed to explore the environment for 1 min, during which time baseline levels 
of freezing and exploratory behaviour were observed. Odours (CS+ or CS-) were then 
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presented for 5 min each to the animal in a counterbalanced order, and the amount of 
time freezing was recorded. Freezing was defined as complete immobility with the 
exception of respiratory-related movement. We also analyzed exploratory behaviour 
in response to presentations of CS+ or CS- odours, as described previously 
(Rosenkranz and Grace, 2003). Exploratory behaviour was scored as follows, with a 
score assigned for every min of each of the 5 min during the CS+ or CS- odour 
presentations: 0, no locomotion; 1, ambulation across one side of the testing chamber; 
2, ambulation across two sides; 3, exploration of the full perimeter of the testing 
chamber; and 4, exploration of the center and entire perimeter of the test chamber. To 
examine the effects of DA D1 receptor manipulation on the “recall” phase of learned 
emotional memory, microinfusions were given directly before testing (24 hours after 
fear conditioning). To examine the effects of DA D1 receptor manipulation on the 
“reconsolidation” phase of learned emotional memory, microinfusions were given 
directly after the first recall test (24 hrs post-conditioning), and rats were then re-
tested 48 hrs to determine if post-recall experimental manipulations led to alterations 
in the subsequent recall of the same memory. Experimental procedures fear 
conditioning experiments we present a schematic illustration in Fig. 4.1C showing our 
procedure in terms of timelines and methods of drug administration for challenging 










Figure 4.1  Histological analysis of intra-PLC microinjection sites and experimental 
protocol.  
(A) Microphotograph of a representative injector placement within the mPFC. (B) 
Schematic illustration showing representative bilateral placements of microinjection 
cannulae. For illustrative clarity, only a subset of experimental groups is presented. 
Symbols represent separate experimental groups; ▵, SKF81297 100 ng/0.5 µl vs. 
expression of olfactory fear conditioning; □, SKF81297 100 ng/0.5 µl co-administered 
with Rp-cAMP 500 ng/0.5 µl vs. expression of olfactory fear conditioning; ▾, SKF81297 
100 ng/0.5 µl vs. morphine CPP; ●, SKF81297 100 ng/0.5 µl co-administered with Rp-
cAMP 500 ng/0.5 µl vs. morphine CPP. (C) Schematic representation showing 
experimental associative fear conditioning assay and timeline for examining acquisition 
(encoding), expression (expression), and reconsolidation phases of associative olfactory 










4.2.3 Place conditioning 
All rats were conditioned using an unbiased, fully counterbalanced CPP procedure, as 
described previously (Laviolette and van der Kooy, 2002; Laviolette and van der 
Kooy, 2003). Conditioning took place in one of two environments, which differed in 
color, texture, and scent. One environment was white with a wire mesh floor, covered 
in wood chips. The other environment was black with a smooth Plexiglas floor, wiped 
down with a 2% acetic acid solution before each conditioning session. Rats display no 
baseline preference for either of these two environments (Laviolette and van der 
Kooy, 2003). During pre-conditioning (24 h prior to conditioning), rats were placed in 
gray Plexiglas boxes for 30 min to minimize stress during future conditioning. Rats 
received intraperitoneal (i.p.) injections of either morphine (5 mg/kg) or saline vehicle 
in an alternating order for eight days. This conditioning dose of morphine produces 
robust CPP that is behaviourally observable at least 14 days post-conditioning 
(unpublished observations). Immediately after injections, rats were placed in one of 
the two conditioning environments for 30 min. Rats received four drug-environment 
and four saline-environment conditioning sessions. At testing, rats received bilateral 
intra-PLC microinfusions of either saline vehicle, the D2 receptor agonist quinpirole 
(100–1000 ng/0.5 µl) or the full D1 receptor agonist SKF81297 (10–1000 ng/0.5 µl) 
administered alone or co-administered with cAMP inhibitor Rpt-cAMP (doses of 100 
or 500 ng/0.5 µl). At testing, rats were placed on a narrow, neutral gray zone that 
separated the test environments. Time spent in each environment was digitally 
recorded for 10 min. This procedure was repeated during the second CPP test day, 
with bilateral infusions of saline vehicle. A cue-induced CPP test was conducted on 
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the third testing day; 5 min before assessing place preference, rats received intra-PLC 
infusions of SKF81297 (100 ng/0.5 µl) as well as i.p. injections of morphine (5 
mg/kg). Times spent in each environment were scored separately for each animal over 
a 10 min test session. Experimental procedures for the morphine CPP experiments are 
schematically summarized in Fig. 4.1D. 
4.2.4 Drug administration 
The DA D1 receptor agonist, SKF81297 (Tocris), DA D1 receptor antagonist, 
SCH23390 (Tocris), DA D2 receptor agonist, quinpirole (Sigma), morphine 
(morphine hydrochloride, MacFarlane-Smith), cyclic adenosine monophosphate 
(cAMP) inhibitor, Rp-cAMP (Biomol), were dissolved in physiological saline (pH 
adjusted to 7.4). For mPFC microinfusions, stainless steel guide cannulae (22 gauge) 
were implanted bilaterally into the PLC through a 28 gauge microinfusion injector 
(Plastics One). Bilateral microinfusions were performed over 1 min through a 
Hamilton syringe. Following this, injectors were left in place for an additional 1 min 
to ensure adequate diffusion from the tip. 
4.2.5 Fear conditioning drug administration 
Bilateral intra-PLC microinjections of either saline vehicle, the selective full D1 
receptor agonist, SKF81297 (Tocris; 10–100 ng/0.5 µl), the D2-like receptor agonist 
quinpirole (100–1000 ng/0.5 µl), or the cAMP inhibitor, Rp-cAMP (Tocris; 100–500 
ng/0.5 µl) were microinfused immediately prior to the testing phase (expression 
challenge). We have previously reported that this in vivo dose range for SKF81297 is 
  
137
behaviourally active in the olfactory fear conditioning paradigm (Chapter 2). While 
no previous studies have specifically examined the effects of intra-PLC quinpirole on 
the expression of fear memory or morphine CPP, this dose range for intra-cranial 
microinfusions of the D2-like receptor agonist quinpirole, has been reported 
previously to produce behavioural effects in rats in terms of increased oral water 
consumption (Amato et al., 2012) and sustain intra-accumbens self-administration 
behaviours in vivo, in rats (Ikemoto et al., 1997). 
4.2.6 Conditioned place preference drug administration 
For experiments examining the effects of intra-mPFC D1 receptor activation, D2 
receptor activation, or cAMP inhibition on morphine reward memory conditioning, 
we used a previously established conditioning dose of morphine (5.0 mg/kg, i.p.), 
which produces robust morphine CPP (Bishop et al., 2010, Sun et al., 2011 and Lintas 
et al., 2011). Intra-mPFC microinjection of either saline vehicle, or the highly 
selective full D1 receptor agonist, SKF81297 (dose 100 ng/0.5 µl), D2-like agonist 
quinpirole (dose 1000 ng/0.5 µl), or cAMP inhibitor Rp-cAMP (dose range 100–500 
ng/0.5 µl) were given immediately prior to testing for morphine reward behaviour. 
4.2.7 Histology 
Following completion of the experiment rats were transcardially perfused, brains 
were removed and stored in formalin with 25% sucrose solution for at least 24 h. 
Brains were then sectioned into 40 µm coronal slices, mounted, and stained using 
cresyl violet to allow for histological analysis of the site of injection. The majority of 
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mPFC placements were localized within the boundaries of the prelimbic cortical area 
(PLC). Rats found to have injectors located outside the anatomical boundaries of the 
PLC were excluded from experimental analyses. 
4.2.8 Data analysis 
Data were analyzed with one or two-way ANOVA followed by Fisher's Least 
Significant Difference (LSD) tests or student's t-tests, where appropriate. Non-
parametric data was analyzed with Friedman's ANOVA Tests and Wilcoxon Signed-
Rank Tests where appropriate. 
4.3 RESULTS 
4.3.1 Histological analysis 
Histological analysis revealed microinfusion injector cannulae placements to be 
bilaterally localized within the anatomical boundaries of the PLC division of the 
mPFC region, as determined by the Atlas of Paxinos and Watson (1996). In Fig. 4.1A, 
we present a microphotograph showing a typical, representative injector placement 
within the PLC. In Fig. 4.1B, we present a schematic illustration showing 
representative intra-PLC bilateral cannulae placements along the rostral–caudal axis. 
Rats found to have placements outside the anatomical boundaries of the PLC were 
removed from analysis. 
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4.3.2 Intra-PLC dopamine D1 receptor activation blocks fear 
memory expression through a D1 receptor-specific substrate 
We have reported previously that DA D1 receptor stimulation in the PLC dose-
dependently blocks the acute expression of previously acquired fear memory over an 
order of magnitude dose range (10–100 ng/0.5 µl) with a lower dose (10 ng/0.5 µl) 
producing no block in fear memory expression vs. a higher dose (100 ng/0.5 µl) that 
completely blocks acute memory expression (Lauzon et al, 2009). In the present study, 
we selected our previously established behaviourally effective dose of intra-PLC 
SKF81297 (100 ng/0.5 µl) to confirm that intra-PLC D1 receptor stimulation induces 
a block in the acute expression of an associative olfactory fear memory. In addition, 
we repeated the lower dose of SKF81297 (10 ng/0.5 µl) to confirm it was not 
sufficient to block acute expression of olfactory fear memory. Furthermore, to 
examine receptor specificity, in a separate experimental group, we co-administered 
the selective D1 antagonist (SCH23390; 1000 ng/0.5 µl) with SKF81297 (100 ng/0.5 
µl) immediately prior to fear conditioning memory expression testing. Analysis of 
conditioned freezing behaviour with two-way ANOVA revealed a significant 
interaction between group and treatment (F(2,47) = 6.53; p < 0.01) on times spent 
freezing to CS+ vs. CS− cue presentations. Post hoc analysis revealed that rats in the 
saline (n = 8) control group and the low dose SKF81297 (10 ng/0.5 µl, n = 8) 
demonstrated significant fear conditioning at testing, with greater amounts of time 
spent freezing to CS+ relative to CS− presentations (p's < 0.01). 
 In contrast, rats receiving intra-PLC SKF81297 (100 ng/0.5 µl) demonstrated 
no behavioural expression of fear memory, demonstrated by the absence of 
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associative freezing behaviour in response to CS+ vs. CS− presentations (n = 8; p > 
0.05). For the group receiving co-administration of the D1 antagonist SCH23390 with 
SKF81297 (n = 8), fear memory expression was restored, demonstrated by associative 
freezing to CS+ relative to CS− presentations (p < 0.01) (Fig. 4.2A). Non-parametric 
analysis (Friedman's ANOVA) of spontaneous exploratory behaviour during 
presentations of either CS+ or CS− revealed a significant effect of treatment (χ2(7) = 
24.95, p < 0.01). Post hoc analysis revealed that both vehicle control rats (n = 8) and 
rats receiving the lower dose of SKF81297 (10 ng/0.5 µl, n = 8) demonstrated 
significant conditioned suppression of exploratory behaviour in response to CS+ 
presentations (p's < 0.05). In contrast, post hoc analysis revealed a significant 
suppression of fear-related exploratory behaviour in the group receiving intra-PLC 
SFK81297 (100 ng/0.5 µl) alone, demonstrated by the absence of conditioned 
suppression of exploratory behaviour in response to CS + presentations (n = 8; p > 
0.05). However, in rats receiving co-administration of SCH23390 with SKF81297 (n 
= 8), conditioned suppression of exploratory behaviour was present following CS+ 
presentations (p < 0.01), demonstrating that the blockade of acute fear memory 
expression via SKF81297 was mediated through a D1 receptor substrate (Fig. 4.2B). 
4.3.3 Dopamine D2 receptor activation in the PLC does not block 
the expression of olfactory fear memory 
To further examine receptor specificity, we examined the effects of intra-PLC D2 
receptor activation on expression of fear memory, comparing the effects of intra-PLC 
microinfusions of either vehicle, SKF81297 (100 ng/0.5 µl) alone, or the selective D2 
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receptor agonist quinpirole (100–1000 ng/0.5 µl) immediately prior to fear 
conditioning testing. Two-way ANOVA revealed a significant interaction between 
group and treatment (F(2,45) = 7.79; p < 0.01) on times spent freezing to either CS+ or 
CS− cue presentations at testing. Post hoc analysis revealed a block in fear memory 
expression by SKF81297 (100 ng/0.5 µl) alone, with no significant difference in times 
spent freezing to CS+ vs. CS− presentations (n = 8; p > 0.05). In contrast, Post hoc 
analysis revealed that vehicle control rats (n = 8), rats receiving intra-PLC quinpirole 
(100 ng/0.5 µl; n = 7) and rats receiving quinpirole (1000 ng/0.5 µl; n = 7) 
demonstrated significant fear conditioning at testing, with greater amounts of time 
spent freezing to CS+ vs. CS− presentations (p's < 0.01; Fig. 4.3A). Non-parametric 
analysis (Friedman's ANOVA) of spontaneous exploratory behaviour during 
presentations of either CS+ or CS− revealed a significant effect of treatment (χ2(7) = 
37.17, p < 0.001). Post hoc analysis revealed a block of conditioned suppression of 
exploratory behaviour by SKF81297 (100 ng/0.5 µl) demonstrated by no significant 
difference in exploratory behaviour in response CS+ vs. CS− presentations (n = 8; p > 
0.05). In contrast, Post hoc analysis revealed that vehicle control rats (n = 8), rats 
receiving intra-PLC quinpirole (100 ng/µl; n = 7) and rats receiving quinpirole (1000 
ng/µl; n = 7) demonstrated associative suppression of exploratory behaviour in 
response to CS+ vs. CS− presentations (p's < 0.01; Fig. 4.3B). Thus, D2 receptor 
activation in the PLC with quinpirole failed to attenuate fear memory expression over 
an order of magnitude dose range, including a dose 10-fold higher than the 





Figure 4.2 Behavioural effects of bilateral intra-PLC DA D1 receptor activation on 
the expression of olfactory fear memory.  
(A) Rats receiving either intra-mPFC saline or the low dose D1 agonist (SKF81297; 10 
ng/0.5 µl) displayed normal expression of fear memory, as shown by significantly higher 
freezing behaviour in response to CS+ presentations compared to CS−. In contrast, 
administration of a D1 agonist (SKF81297; 100 ng/0.5 µl) immediately before testing 
blocked expression of previously acquired fear memories demonstrated by the absence of 
associative freezing behaviour during testing. Receptor specificity was demonstrated 
using bilateral intra-PLC administration of SKF81297 (100 ng/0.5 µl) co-administered 
with a D1 receptor antagonist (SCH23390; 1000 ng/0.5 µl) which rescued normal 
expression of fear conditioning memory with significantly higher freezing behaviour in 
response to CS+ presentations compared to CS−. B, Similar effects were observed in 
conditioned suppression of exploratory behaviour scores following CS+ vs. CS− 
presentations, with intra-mPFC D1 receptor activation blocking conditioned suppression 
of exploratory behaviour following pre-testing microinfusions of SKF81297 (100 ng/0.5 
µl), relative to D1 agonist low dose (10 ng/0.5 µl) and saline control groups. In addition, 
normal expression of exploratory behaviour was rescued by co-administering the D1 
receptor antagonist SCH23390 (1000 ng/0.5 µl) with the D1 receptor agonist, SKF81297 
(100 ng/0.5 µl) with significantly lower exploratory behaviour in response to the CS+ 
compared to the CS−, similar to the saline control group. *p < 0.05; **p < 0.01 for this 


















Figure 4.3 Behavioural effects of bilateral intra-PLC DA D1 and D2 receptor 
activation on expression of olfactory fear memory. 
(A) Rats receiving intra-PLC saline displayed normal expression (expression) of salient 
fear conditioning when administered saline immediately before testing, as shown by a 
significantly higher freezing behaviour in response to CS+ presentations compared to 
CS−. In contrast, administration of a D1 agonist (SKF81297; 100 ng/0.5 µl) immediately 
before testing, completely blocked the expression (expression) of previously acquired 
emotional learning with rats displaying no significant difference in freezing behaviour in 
response to CS+ relative to CS− at testing. In contrast, D2 receptor activation (quinpirole 
1000 ng/0.5 µl) had no effect on expression demonstrating normal expression of fear 
conditioning memory with significantly higher freezing behaviour in response to CS+ 
presentations compared to CS−. (B) Similar effects were observed in conditioned 
suppression of exploratory behaviour scores following CS+ vs. CS− presentations, with 
intra-PLC D1 receptor activation blocking conditioned suppression of exploratory 
behaviour following pre-testing microinfusions of SKF81297 (100 ng/0.5 µl), relative to 
saline controls. In contrast, D2 receptor activation (quinpirole 1000 ng/0.5 µl) had no 
effect on expression demonstrating normal expression of fear conditioning memory with 
significantly lower exploratory behaviour in response to CS+ presentations compared to 















4.3.4 Intra-PLC dopamine D1 receptor-mediated block of fear 
memory expression is transient 
Next, we examined D1 receptor activation-mediated block of fear memory expression 
was transient in nature, or represented a permanent erasure of the original memory. In 
a separate experiment, we administered the previously established effective dose of 
intra-PLC SKF81297 (100 ng/0.5 µl) immediately prior to expression testing, 
followed by a second expression test 24 h later, using intra-PLC saline vehicle 
infusions immediately prior to the test. Two-way ANOVA revealed a significant 
interaction between group and treatment (F(2,47) = 3.59; p < 0.05) on times spent 
freezing to either CS+ or CS− cue presentations during testing phases. Post hoc 
analysis revealed that vehicle control rats (n = 8) demonstrated robust fear memory 
expression at testing, with greater amounts of time spent freezing to CS+ relative to 
CS− presentations (p < 0.01). In contrast, fear memory expression was blocked in rats 
receiving intra-PLC SKF81297 (100 ng/0.5 µl) with no significant difference in time 
spent freezing to the CS+ relative to CS− presentations (n = 8; p > 0.05), during the 
first expression test (Fig. 4.4A). However, during the second expression test (intra-
PLC vehicle), the same rats demonstrated robust expression of the memory, in the 
absence of intra-PLC D1 receptor stimulation, showing significant associative 
freezing in response to CS+ presentations (Fig. 4.4A). Non-parametric analysis 
(Friedman's ANOVA) of spontaneous exploratory behaviour during CS+/CS− 
presentations (Fig. 4.4B) revealed a significant effect of treatment (χ2(5) = 13.43, p < 
0.05). Post hoc analysis revealed saline control rats' demonstrated significant 
associative suppression of exploratory behaviours in response to CS+ relative to CS− 
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presentations (p < 0.01). In contrast, rats receiving intra-PLC SKF81297 
demonstrated no associative suppression of exploratory behaviours (n = 8; p > 0.05). 
However, this same group demonstrated strong suppression of exploratory behaviour 
during the second expression test, in the absence of intra-PLC D1 receptor activation 
(p < 0.05; Fig. 4.4B). These results demonstrate that intra-PLC D1 receptor-mediated 
block of fear memory expression is transient in nature, and that the original memory 
is still intact and can be expressed in the absence of D1 receptor stimulation. 
4.3.5 D1 receptor mediated block of fear memory expression is 
cAMP-dependent 
Next, we examined the potential role of downstream cAMP signaling during D1 
receptor-mediated blockade of fear memory expression. Given that D1 receptor 
activation strongly increases downstream cAMP signaling (Senogles et al., 1988), a 
separate experimental group received co-administration of the cAMP inhibitor, Rp-
cAMP (100–500 ng/0.5 µl), with the previously established effective dose of the D1 
agonist SKF81297 (100 ng/0.5 µl) in order to examine if counteracting the potential 
effects of intra-PLC D1 receptor activation on cAMP signaling may reverse the 
observed block of spontaneous fear memory expression. Intra-mPFC microinjections 
of either saline vehicle, SKF81297 (100 ng/0.5 µl) alone, or SKF81297 (100 ng/0.5 









Figure 4.4  Intra-PLC D1 receptor activation transiently blocks expression of 
olfactory fear memory.  
(A) Rats receiving intra-PLC vehicle displayed normal expression of fear memory, as 
shown by significantly higher freezing behaviour in response to CS+ presentations. As 
previously demonstrated, administration of a D1 agonist (SKF81297; 100 ng/0.5 µl) 
immediately before testing (24 h post conditioning), completely blocked the expression 
of previously acquired fear memory with rats displaying no associative freezing 
behaviour in response to CS+ presentations. The same group was given a vehicle intra-
PLC microinjection immediately before a second expression, 48 h post-conditioning. 
These animals demonstrate normal expression of fear conditioning memory with 
significantly higher freezing behaviour in response to CS+ presentations compared to 
CS−, illustrating that the D1 mediated block of expression is transient in duration. (B) 
Similar effects were observed in exploratory behaviour scores. Vehicle control rats 
displayed normal expression of fear memory, shown by associative suppression of 
exploratory behaviour in response to CS+ presentations whereas intra-PLC D1 receptor 
activation SKF81297 (100 ng/0.5 µl) blocked this effect. The same group tested 48 h 
post-conditioning displayed normal associative suppression of exploratory behaviour, 













 In addition, a separate control group received intra-PLC Rp-cAMP (500 ng/0.5 
µl) alone, to control for any potential non-specific effects of the cAMP inhibitor on 
memory expression (n = 8). Two-way ANOVA revealed a significant interaction 
between group and treatment (F(4,79) = 5.04; p < 0.01) on times spent freezing to either 
CS+ or CS− cue presentations. Post hoc analysis demonstrated a block in associative 
fear conditioning expression by both SKF81297 100 ng/0.5 µl alone (n = 8) and 
SKF81297 100 ng co-administered with Rp-cAMP 100 ng/0.5 µl (n = 8) with no 
significant difference in time spent freezing to the CS+ relative to CS− presentations 
(p's > 0.05). In contrast, post hoc analysis revealed that rats in the Saline (n = 8) 
control group, the group receiving SKF81297 100 ng/0.5 µl co-administered with the 
high dose of Rp-cAMP 500 ng/0.5 µl (n = 8), and the group receiving Rp-cAMP 500 
ng/µl alone (n = 8) demonstrated significant fear conditioning at testing, with greater 
amounts of time spent freezing to CS+ relative to CS− presentations (p's < 0.01; Fig. 
4.5A). Non-parametric analysis (Friedman's ANOVA) of spontaneous exploratory 
behaviour during presentations of either CS+ or CS− revealed a significant interaction 
between group and treatment (χ2(9) = 37.80, p < 0.001). Post hoc analysis illustrated a 
significant suppression of fear conditioning expression by both SKF81297 100 ng/0.5 
µl alone (n = 8) and SKF81297 100 ng co-administered with Rp-cAMP 100 ng/0.5 µl 
(n = 8) demonstrated by no significant difference in exploratory behaviour in response 
CS+ relative to CS− presentations (p's > 0.05). In contrast, post hoc analysis revealed 
that rats in the saline (n = 8) control group, the group receiving SKF81297 100 ng/0.5 
µl co-administered with the high dose of Rp-cAMP 500 ng/0.5 µl (n = 8), and the 
group receiving Rp-cAMP 500 ng/µl alone (n = 8) demonstrated significant fear 
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conditioning at testing, with significantly lower exploratory behaviour in response to 
CS+ relative to CS− presentations (p's < 0.01; Fig. 4.5B). These results demonstrate 
that the D1 receptor mediated block of expression during fear learning is dependent on 
downstream activation of cAMP with the mPFC, as inhibition of cAMP signaling 
dose-dependently rescued the effects of intra-PLC D1 receptor-mediated block of fear 
memory expression, while having no effects in and of itself on acute fear memory 
expression. 
4.3.6 Intra-PLC D1 receptor activation blocks expression of 
spontaneous, but not morphine-primed opiate memory 
expression 
We next examined the effects of intra-PLC D1 receptor activation on reward memory 
expression using our previously established morphine CPP procedure (Laviolette and 
van der Kooy, 2003, Bishop et al., 2010 and Lintas et al., 2011). CPP conditioning 
was performed using a dose of systemic morphine (5 mg/kg, i.p.) which produces 
robust CPP (Bishop et al., 2010 and Lintas et al., 2011) and the effects of D1 
activation were tested by administering SKF81297 (10–100 ng/0.5 µl) directly into 
the PLC immediately before CPP testing. Two-way ANOVA revealed a significant 
interaction between group and treatment (F(2,43) = 3.84; p < 0.05) on times (s) spent in 
the morphine vs. saline-paired testing environments. Post hoc analysis revealed during 
CPP testing animals receiving intra-mPFC saline (n = 6) or the lower dose of D1 
agonist, SKF81297 (10 ng/0.5 µl; n = 8) showed a significant preference for the 





Figure 4.5 Inhibition of cAMP signaling rescues D1-receptor mediated blockade of 
fear memory expression. 
(A) Rats receiving intra-mPFC vehicle displayed normal expression of fear memory, 
demonstrating associative freezing behaviour in response to CS+ presentations. In 
contrast, intra-PLC administration of SKF81297 (100 ng/0.5 µl) alone or co-administered 
with a lower dose of the cAMP inhibitor (Rp-cAMP; 100 ng/0.5 µl) before testing 
blocked expression of fear memory with rats displaying no associative freezing behaviour 
in response to CS+ presentations. However, contrast, intra-PLC co-administration of a 
higher dose of Rp-cAMP (500 ng/0.5 µl) with the D1 agonist (100 ng/0.5 µl) reversed D1 
mediated memory expression blockade, with rats showing normal associative fear-related 
freezing. In a separate control experiment, intra-PLC Rp-cAMP (500 ng/0.5 µl) alone did 
not influence the expression of fear memory, with significantly higher freezing behaviour 
in response to the CS+ presentations. (B) Similar effects were observed in spontaneous 
exploratory behaviour, as rats receiving intra-PLC vehicle showing significantly lower 
exploratory behaviour in response to CS+ presentations. Administration of SKF81297 
(100 ng/0.5 µl) alone or co-administered with the lower dose of cAMP inhibitor (Rp-
cAMP; 100 ng/0.5 µl) blocked conditioned suppression of exploratory behaviour in 
response to CS+ presentations. In contrast, intra-mPFC co-administration of the higher 
dose of Rp-cAMP (500 ng/0.5 µl) with the D1 agonist (100 ng/0.5 µl) reversed D1 
mediated suppression of expression, shown by significantly lower CS+-related 
conditioned suppression of exploratory behaviour. Intra-PLC Rp-cAMP (500 ng/0.5 µl) 















 In contrast, animals receiving the higher dose of SKF81297 (100 ng/0.5 µl; n = 
8) demonstrated no morphine CPP (p > 0.05). In a subsequent test, we tested the same 
group for CPP expression following a priming injection of morphine (5 mg/kg; i.p.) 
following intra-PLC administration of the previously determined effective dose of 
SKF81297 (100 ng/0.5 µl; n = 8). Following morphine priming, we found that intra-
PLC D1 receptor activation failed to block the expression of morphine CPP (t(14) = 
5.13; p < 0.01), with the same rats demonstrating a significant preference for the 
morphine-paired environment (Fig. 4.6A). These results demonstrate that intra-PLC 
DA D1 receptor hyperstimulation transiently inhibits the spontaneous expression of 
morphine CPP, but does not block morphine-primed memory expression. 
4.3.7 D1 receptor mediated block of associative opiate reward 
memory is dependent on cAMP activity 
We next examined the possible role of downstream cAMP modulation as a potential 
mediator of intra-PLC D1 receptor-mediated block of spontaneous opiate associative 
reward memory expression. Accordingly, we co-administered a cAMP inhibitor, Rp-
cAMP, with the highest effective dose of SKF81297 (100 ng/0.5 µl) immediately 
prior to CPP expression testing. Two-way ANOVA revealed a significant interaction 
between group and treatment (F(2,47) = 17.83; p < 0.001) on times (s) spent in the 
morphine-paired or saline-paired side of the testing apparatus. Post hoc analysis 
revealed that groups receiving intra-PLC saline (n = 8) or SKF81297 (100 ng/0.5 µl) 
co-administered with the higher dose of Rp-cAMP (500 ng/0.5 µl) showed a 






Figure 4.6 Effects of intra-mPFC D1 receptor activation, cAMP inhibition, and D2 
receptor activation on morphine reward CPP expression. 
 (A) Intra-PLC vehicle controls and rats receiving the lower dose of the D1 agonist 
SFK81297 (10 ng/0.5 µl) displayed significant morphine CPP. In contrast, morphine CPP 
expression was blocked in rats receiving a higher dose of intra-PLC SKF81297 (100 
ng/0.5 µl). However, rats receiving intra-PLC SKF81297 (100 ng/0.5 µl) following a 
morphine priming injection (5 mg/kg; i.p.) displayed a significant morphine CPP. (B) 
Vehicle controls and rats receiving a lower dose of the cAMP inhibitor Rp-cAMP (100 
ng/0.5 µl) co-administered with the effective dose of SKF81297 (100 ng/0.5 µl) displayed 
significant morphine CPP. In contrast, morphine CPP expression was blocked in animals 
receiving a higher dose of intra-PLC Rp-cAMP (500 ng/0.5 µl) co-administered with 
SKF81297 (100 ng/0.5 µl). (C) In contrast, vehicle controls and or receiving intra-PLC 
microinfusions of the D2 receptor agonist quinpirole (100–1000 ng/0.5 µl) displayed 






 In contrast, animals receiving the D1 agonist, SKF81297 (100 ng/0.5 µl) co-
administered with a lower dose of Rp-cAMP inhibitor (100 ng/0.5 µl) did not show 
morphine CPP, with no significant difference in times spent in morphine vs. saline-
paired environments (p > 0.05) (Fig. 4.6B). Thus, similar to effects observed during 
olfactory fear memory expression, inhibition of cAMP signaling dose-dependently 
rescued the memory expression blocking effects of intra-PLC D1 receptor activation 
during opiate reward memory expression testing. 
4.3.8 Opiate reward memory expression is not dependent upon 
dopamine D2 receptor activation 
In a separate experiment, we next examined the potential role of intra-PLC DA D2 
transmission during the expression of associative opiate reward memory, by 
performing bilateral intra-PLC micro-infusions of the D2 selective receptor agonist, 
quinpirole (100–1000 ng/0.5 µl) prior to morphine CPP testing, as previously 
described. Statistical analysis revealed a significant effect of treatment (F(1,43) = 
81.6308; p < 0.0001) on times (s) spent in morphine vs. saline-paired environments 
during CPP testing. Post hoc analysis revealed that DA D2 receptor activation had no 
effect on behavioural expression of morphine CPP in neither saline controls (n = 8), 
nor in groups receiving intra-PLC quinpirole over an order of magnitude dose range 
(100–1000 ng/0.5 µl; n's = 8), with all groups demonstrating significant CPP for 
morphine-paired environments (p's < 0.05; Fig. 4.6C). Thus, similar to effects 
observed during olfactory fear memory expression, block of spontaneous opiate 
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reward memory expression appears to be independent of D2 receptor signaling in the 
PLC. 
4.4 DISCUSSION 
The activation of neuronal networks within the mPFC is associated with the 
expression of various forms of memory. For example, neuronal populations in the 
PLC division of the mPFC encode and express associative information related to 
opiate reward-related memories (Sun et al., 2011 and Sun and Laviolette, 2012). 
Furthermore, neurons within the mPFC can encode and express associative learning 
related to aversive stimulus conditioning, such as olfactory fear-related memories 
(Laviolette et al., 2005 and Laviolette and Grace, 2006a). These results demonstrate 
that the acquisition and expression of emotionally salient associative memories 
engages mPFC neuronal networks across rewarding and aversive emotional valences. 
Furthermore, considerable evidence suggests that these processes are dependent upon 
specific DA receptor-subtype transmission (Laviolette et al., 2005, Lauzon et al., 
2009 and Pezze et al., 2003). However, less is understood regarding how DAergic 
transmission within the mPFC can control the spontaneous expression of previously 
acquired emotionally salient memories, particularly across memory expression across 
rewarding vs. aversive conditioning events. 
 DAergic modulation of mPFC neuronal networks is known to control the 
encoding of working memory and the temporal sequencing of behavioural output 
(Goldman-Rakic, 1995, Goldman-Rakic et al., 1989 and Seamans et al., 1998). 
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Previous investigations have demonstrated that intra-mPFC activation of D1 receptors 
impairs spatial working memory performance (Zahrt et al., 1997) and delayed 
response performance (Arnsten et al., 1994 and Cai and Arnsten, 1997). Current 
theories of mPFC DA function have suggested that D1 receptor transmission may be 
critical for the preservation and expression of memories over temporal delay periods 
(Durstewitz and Seamans, 2008) although few studies have examined directly the role 
of mPFC D1 receptor transmission during the expression of emotionally salient 
associative memories. Seamans et al. (1998) reported that blockade of mPFC D1 
receptors blocked the ability of rodents to use previously acquired spatial memory 
during a delayed performance radial arm task, while having no effect on non-delayed 
memory expression. These studies suggest that executive memory functions within 
mPFC neuronal networks may require an optimal level of DA D1 signaling, 
specifically during periods of memory expression, rather than during associative 
memory encoding. While no previous studies have reported that intra-PLC 
stimulation of D1 receptor signaling may block spontaneous expression of either 
aversive or rewarding associative memories, the present results are consistent with the 
concept that an optimal level of D1 receptor signaling is required for spontaneous 
expression of previously acquired associative learning. Previous research has 
implicated the importance of optimal D1 receptor signaling by demonstrating an 
inverted ‘U’ shaped function for the effects of D1 receptor stimulation on PFC 
neuronal activity and correlated cognitive performance in primates (Vijayraghavan et 
al., 2007). Thus, while low level D1 receptor stimulation tended to enhance neuronal 
spatial tuning during a spatial working memory task, high stimulation levels impaired 
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performance both at the neuronal and behavioural levels. We have previously 
reported no effect of intra-mPFC D1 receptor stimulation on the acquisition of fear-
related memory, over an order of magnitude dose range in rats (Lauzon et al., 2009). 
In addition, in the present study, lower doses of intra-PLC D1 agonists had no 
apparent memory enhancing effects in terms of behavioural performance. However, 
both fear conditioning and CPP represent relatively simple, Pavlovian conditioning 
procedures, whereas previously cited studies used more complex cognitive tasks in 
both primate and rodent behavioural assays. While future studies are required to 
examine these differences, one possibility is that the cognitive enhancing effects of 
low level D1 receptor stimulation may be observed more specifically in tasks 
requiring greater cognitive load, as opposed to more basic associative memory 
procedures. 
4.4.1 D1 receptor activation modulates memory expression 
through a cAMP-dependent substrate 
Functionally, DA transmission within the mPFC influences neuronal network activity 
in a biphasic manner, with D2-like receptor activation decreasing the activity of 
GABAergic interneurons, and D1 receptor activation increasing the intrinsic 
excitability of these inhibitory interneurons (Seamans et al., 2001). Specifically, 
activation of D1 receptors increases the activity of adenylate cyclase, in turn 
increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and 
protein kinase A (PKA; Kebabian and Calne, 1979). Within mPFC neuronal circuits, 
these events are believed to lead to increased activity of GABAergic interneurons and 
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feedforward inhibition of mPFC pyramidal output neurons (Starr, 1987, Kebabian and 
Calne, 1979, Laviolette and Grace, 2006b, Lauzon et al., 2009 and Seamans et al., 
2001). Thus, intra-mPFC D1 receptor activation may ultimately trigger a downstream 
cascade, increasing feedforward inhibition of mPFC neuronal networks required for 
the acute expression of associative memories. Anatomically, the rodent mPFC is 
highly heterogeneous, comprising various subpopulations of interneuronal and 
pyramidal output neuron populations. In terms of DA transmission, D1 and D2 
receptors are found ubiquitously throughout these neuronal populations. However, 
some studies have suggested a preferential localization of the D1 receptor on non-
pyramidal, presumptive interneuron mPFC populations (Vincent et al., 1993 and 
Sesack and Bunney, 1989). Given that neuronal populations within the mPFC can 
store associative memories linked to both aversive and rewarding events, increasing 
cAMP/PKA signaling within the mPFC via D1 receptor activation may lead to 
increased feedforward inhibition on mPFC pyramidal neurons, thereby impairing the 
expression of olfactory fear associations or opiate reward associations (Starr, 1987, 
Seamans et al., 2001, Laviolette and Grace, 2006b and Lauzon et al., 2009). 
Furthermore, given the critical involvement of the BLA in the processing of both fear 
and reward-related associative memories (Lintas et al., 2011 and Tan et al., 2011), D1 
receptor activation within the PLC may modulate memory recall via descending 
influences on BLA neuronal populations. 
 In addition to the traditional D1-AC-cAMP pathway, it is important to note that 
D1 receptor transmission can produce bidirectional modulation of neuronal activity 
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via different intracellular cascades. DA input provides a state dependent dynamic 
regulation of intracellular cascades allowing for different mechanisms of intracellular 
Ca2+ potentials by acting though PKA or protein kinases C (PKC) pathways. It has 
been demonstrated within pyramidal neurons. In terms of the present findings, 
simultaneous inhibition of cAMP rescued DA D1-receptor mediated block of both 
aversive and rewarding associative memories, suggesting a common molecular 
pathway within the PLC involving D1/cAMP signaling. Our findings are consistent 
with a previous report demonstrating that co-administration of a cAMP activator can 
similarly rescue the cognitive impairment induced by intra-mPFC D1 receptor 
overstimulation in primates performing a delayed spatial memory task, further 
demonstrating the important functional link between intra-cortical D1 receptor 
transmission and cognitive processing (Vijayraghavan et al., 2007). Interestingly, in 
the context of reward-related learning and memory, previous evidence has 
demonstrated that cAMP/PKA stimulation or inhibition directly within the nucleus 
accumbens, can disrupt the acquisition of reward-related memory, specifically, the 
acquisition of amphetamine-conditioned CPP (Beninger et al., 2003). Thus, 
cAMP/PKA signaling may be critical not only for the expression of drug reward-
related memories, but may be necessary for the acquisition of these memories as well. 
 Although the spontaneous expression of opiate reward memory CPP was dose-
dependently blocked by acute intra-PLC D1 receptor activation, when rats were given 
a morphine priming injection immediately prior to expression testing, concomitant 
with intra-PLC D1 receptor activation, we observed normal expression of the CPP 
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behaviour. This demonstrates that the ability of D1 receptor activation to disrupt 
morphine reward memory expression can be prevented by the presence of the 
morphine conditioning prime. Importantly, this result also demonstrates that D1 
receptor activation was not preventing behavioural expression of the morphine CPP 
via performance disruption, since the same dose of SKF81297 failed to block 
morphine CPP expression in the presence of the morphine priming dose. Previous 
research has suggested that the retrieval of morphine-related associative memories is 
more likely to occur in the presence of the morphine conditioning cue during 
expression testing (Izquierdo and Dias, 1983 and Darbandi et al., 2008). In addition, 
morphine state-dependent memory retrieval can be mediated by neurotransmitter 
systems other than DA, including muscarinic acetylcholine receptors within the 
amygdala and ventral tegmental area (Darbandi et al., 2008 and Rezayof et al., 2009). 
Thus, the present results may suggest that the administration of a morphine priming 
injection may counteract the effects of intra-PLC D1 receptor-mediated memory 
expression suppression. Alternatively, exposure to the morphine conditioning prime 
during CPP testing may activate a state-dependent memory pathway that triggers 
behavioural expression of the original memory, bypassing D1 receptor-dependent 
expression mechanisms within the PLC. 
4.4.2 Potential implications for memory-related neuropsychiatric 
disorders 
The obtrusive and spontaneous expression of associative memories linked to either 
traumatic or highly rewarding experiences may be a critical factor underlying the 
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pathological features of disorders such as PTSD or addiction. PTSD patients may 
associate a wide variety of sensory stimuli with intense fear (Rothbaum and Davis, 
2003). While the specific role of D1 signaling in the context of PTSD has not been 
extensively examined in clinical populations, abnormally low levels of cAMP 
signaling have been found to be a persistent correlate of PTSD in clinical populations 
(Kolb, 1989) leading to the suggestion that lowered cAMP signal transduction may 
serve as a clinical biomarker for PTSD (Lerer et al., 1987). DA D1 receptor 
stimulation is critically linked to downstream regulation of cAMP (Senogles et al., 
1988) and in the present study, the effects of intra-PLC D1 receptor stimulation on 
blockade of spontaneous fear memory expression were reversed by concomitant 
suppression of cAMP activity. Together with the well-established profound decreases 
in cAMP levels observed in PTSD clinical populations, the present results may have 
implications for understanding how DA D1-mediated inhibition of cAMP levels may 
modulate spontaneous expression of traumatic associative memories through PFC-
dependent memory circuits. Indeed, considerable evidence points to 
neuropathological abnormalities within frontal cortical regions of PTSD patients as 
potential clinical correlates of PTSD-related memory disturbances and lack of control 
over traumatic memory expression (Tavanti et al., 2012 and Carrion et al., 2009). 
 In the context of addiction-related memories, neurons within the mPFC both 
encode and express associative memories linked to the rewarding properties of 
opiates (Sun et al., 2011 and Sun and Laviolette, 2012). Furthermore, activation of 
mPFC neuronal circuits is linked to various drug-seeking behaviours (Daglish et al., 
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2001, Luo et al., 2004, Koya et al., 2006 and Langleben et al., 2009). The formation 
and persistence of these drug-related associative memories can trigger drug-seeking 
behaviours or relapse in response to drug-associated stimuli (de Wit and Stewart, 
1981 and Ehrman et al., 1992). The present findings demonstrate that transmission 
through a D1 receptor-specific substrate within the PLC is involved critically in the 
spontaneous expression of opiate-related reward memories. Indeed, considerable 
evidence has linked D1 receptor transmission to psychostimulant drug-related 
memory expression. For example, D1 receptor activation has been shown to decrease 
cocaine-seeking behaviour in rats, whereas D2 receptor activation triggers cocaine-
seeking behaviour and relapse (Self et al., 1996). In addition, D1 receptor activation 
has been reported to induce extinction like behaviours in rats that have previously 
acquired cocaine-related self-administration behaviours, suggesting that stimulation 
of D1 transmission may degrade previously acquired drug-related associative 
memories (Self et al., 2000). While the current experiments examined only the acute 
expression of a previously acquired associative opiate reward memory, an interesting 
possibility is that intra-PLC D1 receptor stimulation may trigger a memory extinction-
like process for opiate-related associative memory over longer term administration. In 
the present study, D1 receptor stimulation directly within the PLC blocked the 
spontaneous expression of a morphine-related associative reward memory.  
 Interestingly however, D1 activation did not block morphine reward memory 
expression in the presence of a morphine prime, suggesting that, similar to effects 
observed with fear conditioned memory, supra-normal stimulation of D1 receptor 
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transmission within the PLC transiently prevents the expression of opiate-related 
reward memory, while leaving the original associative memory intact. Alternatively, 
the re-activation of the morphine associative memory in the presence of the morphine 
conditioning cue may be sufficient to overcome the effects of intra-PLC D1 receptor 
activation, or activate the memory through a DA-independent memory mechanism. 
Similar to the effects observed with D1-receptor mediated modulation of associative 
fear memory, the transient blockade of drug-related reward memory was dependent 
upon downstream cAMP signaling, as inhibition of cAMP rescued D1-receptor 
activation mediated memory expression blockade. Alternatively, while we observed a 
block in the behavioural expression of previously acquired associative memories, 
considering that it is possible to dissociate memory recall from behavioural 
expression, it is important to consider the possibility that these conditioned memories 
may have been recalled, but were masked due to an inability to behaviorally express 
them during testing. 
4.5 SUMMARY 
We report that specific activation of D1 receptor transmission within the PLC can 
transiently block the spontaneous expression of associative memories linked to either 
emotionally aversive or rewarding conditioning events. In both cases, D1 receptor 
activation appeared to leave the original memory trace intact, as animals were able to 
express the original memory in the absence of D1 receptor activation, or in the case of 
associative opiate reward memories, in the presence of the original drug cue. These 
effects were dependent upon downstream cAMP stimulation as simultaneous 
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inhibition of cAMP reversed the effects of D1 activation on the blockade of memory 
expression. These findings demonstrate that supra-normal stimulation of D1 receptors 
within the PLC can generally disrupt spontaneous associative memory expression, 
regardless of emotional valence. Together with previously discussed evidence, our 
results further implicate the critical role of intra-cortical D1 receptor signaling during 
the expression of previously acquired learning and memory tasks, across a wide range 
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Chapter 5:  
 
 



















5.1 SUMMARY OF RESULTS AND CONCLUSIONS 
5.1.1 DA D4 versus D1 subtype receptor transmission within the 
mPFC plays distinct functional roles in emotional learning 
and memory 
The findings in Chapter 2 begin to explain the complex role for DA transmission 
within the mPFC during the processing of emotional and cognitive information. 
Specifically, the existence of an optimal level of DA transmission in the mPFC 
function and that overstimulation of the DA D1 or D4 receptor subtypes in the mPFC 
can disrupt adaptive associative learning and memory. Given the ability of D4 
receptor activation to amplify DA-mediated neuronal activity within the mPFC (Ceci 
et al., 1999), we hypothesized that activation of mPFC D4 receptors may potentiate 
the emotional salience of normally subthreshold sensory stimuli, leading to 
heightened emotional memory encoding. We found that specific activation of DA 
D4 receptors within the mPFC strongly potentiates the salience of normally nonsalient 
emotional associative fear memories and blocks the encoding of suprathreshold 
conditioned fear associations. However, D4 receptor activation has no effect on the 
recall of previously learned emotionally salient conditioned memories. In contrast, 
intra-mPFC D1 receptor activation failed to increase the emotional salience of 
subthreshold fear stimuli but completely blocked the expression of previously learned 
emotionally relevant information, demonstrating that DA D4 versus D1 subtype 
receptor transmission within the mPFC plays distinct functional roles in the 
processing of emotionally salient versus nonsalient associative information and 
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differentially modulates the encoding versus recall phases of emotional memory 
within the mPFC (Lauzon et al.., 2009). 
5.1.2 CaMKII bidirectionally regulates fear memory salience via 
DA D4 transmission in the mPFC 
The intriguing and dynamic relationship of DA D4 receptor activation within the 
prelimbic (PLC) division of the mPFC leads to a bidirectional modulation of 
emotional memory by strongly potentiating the salience of normally non-salient 
emotional memories, but blocking the acquisition of suprathreshold emotionally 
salient fear memories. These behavioural effects add to previous in vitro studies 
demonstrating that activation of cortical DA D4 receptors can bidirectionally 
modulate levels of CaMKII, a molecule essential for learning and memory (Gu and 
Yan 2004; Gu et al. 2006). Taken together, we began our exploration into regulation 
of intracellular CaMKII levels as a possible mechanism underlying the functional, 
bidirectional effects of DA D4 receptor activation. We report that CaMKII blockade 
prevents the ability of intra-mPFC DA D4 receptor activation to potentiate the 
salience of subthreshold fear memory. In contrast, blockade of either cAMP/PKA or 
PP1 signaling pathways rescued the blockade of suprathreshold fear memory via 
intra-mPFC D4 receptor activation. Our results demonstrate that modulation of 
emotional memory salience via intra-mPFC DA D4 receptor transmission depends 
upon downstream signaling via CaMKII, cAMP/PKA, and PP1 substrates. These 
findings add to a growing body of evidence linking CaMKII signaling to the aberrant 
emotional regulation present in schizophrenia-related psychoses, and provide a 
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potential DA receptor-specific substrate through which CaMKII signaling may 
control emotional salience processing and memory formation (Malenka and Nicoll 
1999; Frankland et al. 2001). Furthermore, the present results identify several 
downstream molecular targets of intra-PLC D4 receptor substrates, such as CaMKII, 
which may serve as potential pharmacotherapeutic targets in the context of aberrant 
D4 receptor signaling linked to dysregulated emotional processing and memory 
encoding in psychiatric illnesses such as schizophrenia, ADHD, and addiction 
(Lauzon et al., 2012). 
5.1.3 D1 receptor activation modulates associative memory recall 
through a cAMP-dependent substrate 
In our final investigations of this thesis, we demonstrate that specific activation of DA 
D1 receptors in the prelimbic (PLC) division of the mPFC causes a transient block in 
the recall of both aversive and rewarding associative memories. We report that intra-
PLC microinfusion of a selective D1 receptor agonist blocks the spontaneous recall of 
an associative olfactory fear memory without altering the stability of the original 
memory trace. Furthermore, using an unbiased place conditioning procedure (CPP), 
intra-PLC D1 receptor activation blocks the spontaneous recall of an associative 
morphine (5 mg/kg; i.p.) reward memory, while leaving cue-induced morphine 
reward memories intact. Interestingly, both intra-PLC D1-receptor mediated blockade 
of either fear-related or reward-related associative memories were dependent upon 
downstream cyclic-AMP (cAMP) signaling as both effects were rescued by co-
administration of a cAMP signaling inhibitor. The blockade of both rewarding and 
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aversive associative memories are mediated through a D1-specific signaling pathway, 
as neither forms of spontaneous memory recall were blocked by intra-PLC 
microinfusions of a D2-like receptor agonist. Our results demonstrate that the 
spontaneous recall of either rewarding or aversive emotionally-salient memories share 
a common, D1-receptor mediated substrate within the mPFC. Our findings have 
important implications for understanding disorders such as post-traumatic stress 
disorder and addiction, both of which are characterized by the obtrusive recall of 
memories linked to either aversive experiences, or drug-related reinforcement 
memories (Lauzon et al., 2013).  
5.1.4 Limitations 
Currently, neuroscientists are working to characterize the complex functions of 
monoamine neurotransmitter systems in various neural pathways. In most current 
investigations, this involves investigating the effect of a given monoamine in 
isolation. Although this approach has lead to a wealth of knowledge, it is important to 
bear in mind that a given monoamine is seldom released in isolation. Moreover, DA, 
cannabinoid, and serotonin receptors coexist in the mPFC (Santana et al., 2004; 
Santana et al., 2009; Amargós-Bosch et al., 2004), and many of their intracellular 
signaling pathways overlap (Di Pietro & Seamans JK, 2007). At the molecular level, 
cannabinoid, serotonin, and DA receptors may synergistically interact with one 
another in the mPFC, potentiating each other’s downstream effects through cyclic 
AMP and other signaling cascades, suggesting that these neurotransmitter systems 
may modulate emotional processing mechanisms through these functional interactions 
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(Iyer and Bradberry, 1996; Andersson et al., 2005; Kearn et al., 2005). Increasing 
evidence suggests that it is not only the case that multiple monoamines might be 
released simultaneously, but once released they interact in a complex functionally 
significant manner. Therefore, instead of thinking of one specific neurotransmitter 
and its related intracellular pathway as ‘the key’ modulator of emotional learning in 
the mPFC, it is more realistic to envision that multiple neurotransmitter systems and 
downstream molecular pathways together play supporting roles within the complex 
neural circuitry underlying normal cognitive functioning. The ultimate goal of my 
thesis is to contribute to a better understanding of differential DA receptor function 
within the mPFC, with the hope that this knowledge builds a more cohesive ‘picture’ 
of the neurobiology underlying the emotional associative learning process. 
5.2 FUTURE DIRECTIONS 
Many critical questions remain regarding the functional interrelationships within the 
mPFC, and specifically how DA receptor transmission modulates neuronal network 
dynamics within the mPFC. Future investigations will aim to further elucidate our 
findings that activation of mPFC D4 receptors bi-directionally modulates the 
emotional salience of fear-conditioning stimuli during acquisition but not expression 
(recall) phases of associative learning. In addition, future investigations will explore 
D4 receptor–mediated modulation of CaMKII, cAMP/PKA, and PP1 directly within 
the mPFC as potential underlying molecular mechanisms controlling the salience of 
emotional memory processing and acquisition. For example, In vivo 
electrophysiological evidence demonstrates that D4 receptor agonists can decrease 
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feedforward inhibition on mPFC neurons receiving input from the BLA (Floresco and 
Tse, 2007), suggesting the possibility that our observed potentiation of emotional 
associative memory may be attributable to  a BLA-dependent amplification of 
associative information input from the BLA to the mPFC, in effect “priming” neurons 
in the mPFC to receive emotionally salient associative information from the BLA.   
  To further elucidate the synaptic mechanisms underlying D4 mediated 
modulation of emotional salience, we propose future investigations utilizing in vivo 
electrophysiological techniques. Alterations in synaptic connectivity between 
functionally connected brain regions are well established correlates of associative 
neuronal learning and memory processes. These synaptic changes can be measured in 
a variety of ways, but most typically in terms of long-term-potentiation (LTP) and or/ 
long-term-depression (LTD) of post-synaptic responsiveness to afferent stimulation. 
Recent in vitro work by Yuen and Yan (2011) has demonstrated that D4 receptor–
mediated modulation of CaMKII activity is tightly linked to AMPA receptor synaptic 
activity within the mPFC. Thus, during low mPFC neuronal activity levels, D4-
mediated activation of CaMKII results in a potentiation in AMPA receptor synaptic 
efficacy, whereas during high neuronal activity levels, D4 receptor activity decreases 
CaMKII levels concomitant with decreased AMPA receptor signaling. Given the 
essential role of AMPA-mediated glutamatergic signaling in learning and memory-
related synaptic plasticity, this may provide another potential mechanism by which D4 
signaling within the PLC may control emotional memory formation and processing 
via CaMKII modulation. In vivo, extracellular, or intracellular neuronal recording 
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studies may allow us to more precisely determine emotional associative memory 
encoding and expression at the level of the single neuron (Laviolette et al., 2005; 
Laviolette & Grace, 2006; Rosenkranz & Grace, 2002). Furthermore, such studies 
will allow for a finer analysis of the functional relationships between different 
neuronal populations within the mPFC, such as inhibitory interneuron vs. pyramidal 
output neuron dynamics during specific DA receptor activation or blockade. 
 Previous results have demonstrated an interesting LTP effect following in vivo 
emotional associative learning in single neurons of the mPFC (Laviolette et al., 2005). 
These effects are not observed in neurons that do not show functional inputs from the 
BLA. This suggests that a specific functional circuit from the BLA to the mPFC may 
be potentiated as a direct consequence of associative learning in vivo. While our 
preliminary experiments have demonstrated this basic phenomenon up to 60 minutes 
post-conditioning, we further propose a series of pharmacological experiments to 
determine the possible role of DA D1 and D4 receptor subtype transmission in the 
modulation of this BLA↔mPFC learning induced plasticity. Thus, if our observed 
LTP effect along the BLA↔mPFC pathway is functionally related to this emotional 
associative learning process, we would expect a similar blockade of this LTP using 
DA D4 receptor agonists at doses that prevent acquisition of associative neuronal 
encoding (Laviolette et al., 2005). Similar experiments could be conducted to analyze 
the potential involvement of CaMKII downstream pathways, including AMPA-
mediated transmission in the mPFC. Indeed, current unpublished observations in our 
laboratory have demonstrated that D4 receptor-mediated potentiation of sub-threshold 
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fear memories is dependent upon AMPA receptor transmission, while blockade of 
suprathreshold fear memory acquisition can be rescued by positive allosteric 
modulation of AMPA receptor transmission within the mPFC. 
 Together, our behavioural investigations presented in this dissertation and 
proposed future in vivo electrophysiological studies are and will be critical to further 
elucidate the role of DAergic dysregulation in the pathophysiology of cognitive 
dysfunction in psychiatric disorders such as schizophrenia, ADHD, PTSD, and 
addiction, as well as novel therapeutics for cognitive impairments observed in them. 
Furthermore, it is hoped that these lines of research will ultimately lead to the 
identification of novel pharmacotherapeutics for the debilitating emotional and 
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